YUME INC, 10-K filed on 3/10/2015
Annual Report
Document And Entity Information (USD $)
12 Months Ended
Dec. 31, 2014
Feb. 27, 2015
Jun. 30, 2014
Document and Entity Information [Abstract]
 
 
 
Entity Registrant Name
YuMe Inc 
 
 
Document Type
10-K 
 
 
Current Fiscal Year End Date
--12-31 
 
 
Entity Common Stock, Shares Outstanding
 
33,324,473 
 
Entity Public Float
 
 
$ 123,246,516 
Amendment Flag
false 
 
 
Entity Central Index Key
0001415624 
 
 
Entity Current Reporting Status
Yes 
 
 
Entity Voluntary Filers
No 
 
 
Entity Filer Category
Accelerated Filer 
 
 
Entity Well-known Seasoned Issuer
No 
 
 
Document Period End Date
Dec. 31, 2014 
 
 
Document Fiscal Year Focus
2014 
 
 
Document Fiscal Period Focus
FY 
 
 
Condensed Consolidated Balance Sheets (Current Period Unaudited) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Current assets:
 
 
Cash and cash equivalents
$ 38,059 
$ 42,626 
Marketable securities
26,158 
7,295 
Accounts receivable, net
68,441 
65,493 
Prepaid expenses and other current assets
3,642 
2,572 
Total current assets
136,300 
117,986 
Marketable securities, long-term
2,428 
14,186 
Property, equipment and software, net
10,407 
6,610 
Goodwill
3,902 
3,902 
Intangible assets, net
1,329 
2,049 
Restricted cash
292 
292 
Deposits and other assets
384 
362 
Total assets
155,042 
145,387 
Current liabilities:
 
 
Accounts payable
11,692 
7,722 
Accrued digital media property owner costs
18,277 
17,359 
Accrued liabilities
16,338 
12,734 
Deferred revenue
198 
314 
Capital leases, current
41 
359 
Total current liabilities
46,546 
38,488 
Capital leases, non-current
 
22 
Other long-term liabilities
117 
139 
Deferred tax liability
431 
773 
Total liabilities
47,094 
39,422 
Stockholders’ equity:
 
 
Preferred stock: $0.001 par value; 20,000,000 shares authorized, no shares issued and outstanding as of December 31, 2014 and December 31, 2013
 
Common stock: $0.001 par value; 200,000,000 shares authorized as of December 31, 2014 and 2013; 33,066,327 and 31,933,862 shares issued and outstanding as of December 31, 2014 and 2013, respectively
33 
32 
Additional paid-in-capital
138,497 
127,690 
Treasury stock: 66,666 shares as of December 31, 2014 and 2013
 
Accumulated deficit
(30,422)
(21,677)
Accumulated other comprehensive loss
(160)
(80)
Total stockholders’ equity
107,948 
105,965 
Total liabilities and stockholders’ equity
$ 155,042 
$ 145,387 
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) (USD $)
Dec. 31, 2014
Dec. 31, 2013
Preferred Stock, shares authorized
20,000,000 
20,000,000 
Preferred Stock, shares issued
Preferred Stock, shares outstanding
Preferred stock par value (in Dollars per share)
$ 0.001 
$ 0.001 
Common stock, par value (in Dollars per share)
$ 0.001 
$ 0.001 
Common stock, shares authorized
200,000,000 
200,000,000 
Common stock, shares issued
33,066,327 
31,933,862 
Common stock, shares outstanding
33,066,327 
31,933,862 
Treasury stock, shares
66,666 
66,666 
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Revenue
$ 177,779 
$ 151,128 
$ 116,744 
Cost of revenue
93,096 
80,242 
62,985 
Gross profit
84,683 
70,886 
53,759 
Operating expenses:
 
 
 
Sales and marketing
65,112 
47,118 
31,385 
Research and development
5,908 
4,499 
2,766 
General and administrative
21,736 
17,992 
12,466 
Total operating expenses
92,756 
69,609 
46,617 
Income (loss) from operations
(8,073)
1,277 
7,142 
Interest and other income (expense)
 
 
 
Interest expense
(8)
(47)
(117)
Other income (expense), net
(888)
(239)
(147)
Total interest and other income (expense)
(896)
(286)
(264)
Income (loss) before income taxes
(8,969)
991 
6,878 
Income tax (expense) benefit
224 
(670)
(612)
Net income (loss)
(8,745)
321 
6,266 
Net income (loss) attributable to common stockholders
$ (8,745)
$ 321 
$ 89 
Net income (loss) per share attributable to common stockholders:
 
 
 
Basic (in Dollars per share)
$ (0.27)
$ 0.02 
$ 0.02 
Diluted (in Dollars per share)
$ (0.27)
$ 0.02 
$ 0.02 
Weighted-average shares used to compute net income (loss) per share attributable to common stockholders:
 
 
 
Basic (in Shares)
32,591 
15,752 
4,716 
Diluted (in Shares)
32,591 
17,250 
5,545 
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Net income (loss)
$ (8,745)
$ 321 
$ 6,266 
Other comprehensive income (loss):
 
 
 
Foreign currency translation adjustments
(58)
45 
(69)
Unrealized loss on marketable securities, net of tax
(22)
(7)
 
Other comprehensive income (loss)
(80)
38 
(69)
Comprehensive income (loss)
$ (8,825)
$ 359 
$ 6,197 
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (USD $)
In Thousands, except Share data
Convertible Preferred Stock [Member]
Preferred Stock [Member]
Crowd Science Inc [Member]
USD ($)
Convertible Preferred Stock [Member]
Preferred Stock [Member]
USD ($)
Common Stock [Member]
USD ($)
Treasury Stock [Member]
Additional Paid-in Capital [Member]
USD ($)
Retained Earnings [Member]
USD ($)
Accumulated Other Comprehensive Income (Loss) [Member]
USD ($)
Total
USD ($)
Balances at Dec. 31, 2011
 
$ 62,919 
$ 4 
 
$ 3,865 
$ (28,264)
$ (49)
$ (24,444)
Balances (in Shares) at Dec. 31, 2011
 
120,194,247 
3,895,558 
 
 
 
 
 
Issuance of Series D-1 convertible preferred stock, net of issuance costs of $47
 
9,953 
 
 
 
 
 
 
Issuance of Series D-1 convertible preferred stock, net of issuance costs of $47 (in Shares)
 
7,612,087 
 
 
 
 
 
 
Issuance of Series D-1 convertible preferred stock upon acquisition of Crowd Science, Inc., net of issuance costs of $21
3,319 
 
 
 
 
 
 
3,319 
Issuance of Series D-1 convertible preferred stock upon acquisition of Crowd Science, Inc., net of issuance costs of $21 (in Shares)
2,000,000 
 
 
 
 
 
 
2,000,000,000 
Issuance of common stock upon exercise of stock options
 
 
 
700 
 
 
701 
Issuance of common stock upon exercise of stock options (in Shares)
 
 
921,305 
 
 
 
 
921,000 
Income tax benefit from employee stock transactions
 
 
 
 
96 
 
 
96 
Stock-based compensation
 
 
 
 
2,121 
 
 
2,121 
Foreign currency translation adjustment
 
 
 
 
 
 
(69)
(69)
Net income
 
 
 
 
 
6,266 
 
6,266 
Balances at Dec. 31, 2012
 
76,191 
 
6,782 
(21,998)
(118)
(15,329)
Balances (in Shares) at Dec. 31, 2012
 
129,806,334 
4,816,863 
 
 
 
 
 
Issuance of common stock upon exercise of stock options
 
 
 
 
282 
 
 
282 
Issuance of common stock upon exercise of stock options (in Shares)
 
 
215,960 
 
 
 
 
192,000 
Issuance of common stock upon the vesting of restricted stock units (in Shares)
 
 
2,168 
 
 
 
 
 
Issuance of common stock upon the vesting of restricted stock units (in Shares)
 
 
2,168 
 
 
 
 
 
Stock-based compensation
 
 
 
 
4,060 
 
 
4,060 
Foreign currency translation adjustment
 
 
 
 
 
 
45 
45 
Unrealized losses on marketable securities
 
 
 
 
 
 
(7)
(7)
Conversion of preferred stock to common stock
 
(76,191)
22 
 
76,169 
 
 
76,191 
Conversion of preferred stock to common stock (in Shares)
 
(129,806,334)
21,840,537 
 
 
 
 
 
Conversion of preferred stock warrants to common stock warrants
 
 
 
 
426 
 
 
426 
Initial public offering, net of issuance costs
 
 
 
39,971 
 
 
39,976 
Initial public offering, net of issuance costs (in Shares)
 
 
5,125,000 
 
 
 
 
 
Treasury stock (Note 11) (in Shares)
 
 
(66,666)
66,666 
 
 
 
 
Net income
 
 
 
 
 
321 
 
321 
Balances at Dec. 31, 2013
 
 
32 
 
127,690 
(21,677)
(80)
105,965 
Balances (in Shares) at Dec. 31, 2013
 
 
31,933,862 
66,666 
 
 
 
 
Issuance of common stock upon exercise of stock options
 
 
 
3,143 
 
 
3,144 
Issuance of common stock upon exercise of stock options (in Shares)
 
 
801,691 
 
 
 
 
801,691 
Issuance of common stock upon the vesting of restricted stock units (in Shares)
 
 
15,450 
 
 
 
 
 
Issuance of common stock in connection with employee stock purchase plan
 
 
 
 
1,530 
 
 
1,530 
Issuance of common stock in connection with employee stock purchase plan (in Shares)
 
 
315,324 
 
 
 
 
315,324 
Issuance of common stock upon the vesting of restricted stock units (in Shares)
 
 
15,450 
 
 
 
 
 
Stock-based compensation
 
 
 
 
6,134 
 
 
6,134 
Foreign currency translation adjustment
 
 
 
 
 
 
(58)
(58)
Unrealized losses on marketable securities
 
 
 
 
 
 
(22)
(22)
Net income
 
 
 
 
 
(8,745)
 
(8,745)
Balances at Dec. 31, 2014
 
 
$ 33 
 
$ 138,497 
$ (30,422)
$ (160)
$ 107,948 
Balances (in Shares) at Dec. 31, 2014
 
 
33,066,327 
66,666 
 
 
 
 
Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheticals) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Issuance of Series D-1 convertible preferred stock
$ 47 
Crowd Science Inc [Member]
 
Issuance of Series D-1 convertible preferred stock
$ 21 
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Operating activities:
 
 
 
Net income (loss)
$ (8,745)
$ 321 
$ 6,266 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
 
 
 
Depreciation and amortization
4,620 
4,103 
2,783 
Stock-based compensation
5,774 
3,834 
2,042 
Allowances for doubtful accounts receivable
1,154 
493 
393 
Deferred income taxes
(340)
(189)
56 
Excess income tax benefit from the exercise of stock options
 
 
(96)
Amortization of premiums on marketable securities, net
498 
 
 
Change in fair value of preferred stock warrants
 
125 
102 
Changes in operating assets and liabilities, net of effect of acquisition:
 
 
 
Accounts receivable
(4,102)
(17,919)
(16,520)
Prepaid expenses and other current assets
(1,070)
(1,227)
(378)
Deposits and other assets
(22)
173 
(62)
Accounts payable
4,515 
447 
(1,175)
Accrued digital media property owner costs
918 
4,884 
6,530 
Accrued liabilities
3,704 
5,671 
2,486 
Deferred revenue
(116)
(214)
212 
Other liabilities
(22)
(39)
44 
Net cash provided by operating activities
6,766 
463 
2,683 
Investing activities:
 
 
 
Purchases of property and equipment
(5,888)
(1,992)
(1,716)
Capitalized software development costs
(1,996)
(1,752)
(747)
Purchases of marketable securities
(18,231)
(21,488)
 
Acquisition, net of cash acquired
 
 
(844)
Change in restricted cash
 
 
(292)
Net cash used in investing activities
(15,509)
(25,232)
(3,599)
Financing activities:
 
 
 
Proceeds from initial public offering, net of offering costs
 
39,976 
 
Net proceeds from the issuance of convertible preferred stock
 
 
9,953 
Repayments of borrowings under notes payable
 
(185)
(344)
Repayments of borrowings under capital leases
(340)
(632)
(535)
Excess income tax benefit from the exercise of stock options
 
 
96 
Proceeds from exercise of common stock options and warrants
4,574 
282 
701 
Net cash provided by financing activities
4,234 
39,441 
9,871 
Effect of exchange rate changes on cash and cash equivalents
(58)
45 
(69)
Change in cash and cash equivalents
(4,567)
14,717 
8,886 
Cash and cash equivalents—Beginning of period
42,626 
27,909 
19,023 
Cash and cash equivalents—End of period
38,059 
42,626 
27,909 
Supplemental disclosures of cash flow information:
 
 
 
Cash paid for interest
48 
117 
Cash paid for income taxes
930 
440 
85 
Stock-based compensation capitalized for internal-use software
360 
226 
79 
Non-cash investing and financing activities:
 
 
 
Purchases of property and equipment under capital lease obligations
 
 
187 
Purchases of property and equipment recorded in accounts payable
37 
582 
200 
Deferred offering costs recorded in accounts payable and accrued liabilities
 
 
156 
Vesting of early exercised stock options
100 
 
 
Issuance of 2,000,000 shares of Series D-1 preferred stock for acquisition of Crowd Science, Inc.
 
 
3,319 
Maturities of Marketable Securities [Member]
 
 
 
Investing activities:
 
 
 
Proceeds from sale or maturity of Marketable Securities
9,400 
 
 
Sale of Marketable Securities [Member]
 
 
 
Investing activities:
 
 
 
Proceeds from sale or maturity of Marketable Securities
$ 1,206 
 
 
Consolidated Statements of Cash Flows (Parentheticals)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Issuance of shares of Series D-1 preferred stock for acquisition of Crowd Science, Inc.
2,000,000 
Note 1 - Organization and Description of Business
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

1.

Organization and Description of Business


Organization and Nature of Operations


YuMe, Inc. (the "Company") was incorporated in Delaware on December 16, 2004. The Company, including its wholly-owned subsidiaries, is a leading independent provider of digital video brand advertising solutions. The Company's proprietary technologies serve the specific needs of brand advertisers and enable them to find and target large, brand-receptive audiences across a wide range of Internet connected devices and digital media properties. The Company's software is used by global digital media properties to monetize professionally-produced content and applications. The Company facilitates digital video advertising by dynamically matching relevant audiences available through its digital media property partners with appropriate advertising campaigns from its advertising customers.


The Company helps its advertising customers overcome the complexities of delivering digital video advertising campaigns in a highly fragmented environment where dispersed audiences use a growing variety of Internet-connected devices to access thousands of online and mobile websites and applications. The Company delivers video advertising impressions across personal computers, smartphones, tablets, set-top boxes, game consoles, Internet-connected TVs and other devices. The Company's video ads run when users choose to view video content on their devices. On each video advertising impression, the Company collects dozens of data elements that it uses for its advanced audience modeling algorithms that continuously improve brand-targeting effectiveness.


Basis of Presentation


The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”).


In July 2013, the Company's board of directors and stockholders approved an amendment to the amended and restated certificate of incorporation. The amendment provided for a 1-for-6 reverse stock split of the outstanding common stock, effective July 24, 2013. Accordingly, (i) every six shares of common stock were combined into one share of common stock, (ii) the number of shares of common stock into which each outstanding option or warrant to purchase common stock is exercisable, as the case may be, have been proportionately decreased on a 1-for-6 basis, (iii) the exercise price for each such outstanding option or warrant to purchase common stock has been proportionately increased on a 6-for-1 basis, and (iv) the conversion ratio for each share of preferred stock outstanding was proportionately reduced on a 1-for-6 basis. All of the share numbers, share prices, and exercise prices have been adjusted within these financial statements, on a retroactive basis, to reflect this 1-for-6 reverse stock split. The Company paid cash in lieu of any fractional shares to which a holder of common stock would otherwise be entitled as a result of the reverse stock split.


On August 12, 2013, the Company closed the IPO of its common stock pursuant to a registration statement on Form S-1. In the IPO, the Company sold 5,125,000 shares of common stock at a public offering price of $9.00 per share. Net proceeds were approximately $40.0 million, after deducting underwriting discounts and commissions of $3.2 million and offering expenses of $2.9 million. Upon the closing of the IPO, all outstanding shares of the Company’s convertible preferred stock automatically converted into 21,840,537 shares of common stock and all outstanding warrants to purchase convertible preferred stock converted into warrants to purchase 53,983 shares of common stock.


Basis of Consolidation


The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.


Certain Significant Risks and Uncertainties


The Company operates in a dynamic industry and, accordingly, can be affected by a variety of factors. For example, the Company believes that changes in any of the following areas could have a significant negative effect on its future financial position, results of operations, or cash flows: rates of revenue growth; traffic to and pricing with the Company's network of digital media property owners; scaling and adaptation of existing technology and network infrastructure; adoption of the Company’s product and solution offerings; management of the Company's growth; new markets and international expansion; protection of the Company's brand, reputation and intellectual property; competition in the Company's markets; recruiting and retaining qualified employees and key personnel; intellectual property infringement and other claims; and changes in government regulation affecting the Company's business, among other things.


Note 2 - Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]

2.

Summary of Significant Accounting Policies


Use of Estimates


The preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ from management's estimates.


Foreign Currency Translation and Transactions


The consolidated financial statements of the Company's foreign subsidiaries are measured using the local currency as the functional currency, except for India and France, which have U.S. dollar and British pound sterling functional currencies, respectively. Assets and liabilities of foreign subsidiaries are translated at exchange rates in effect as of the balance sheet date. Revenues and expenses are translated at average exchanges rates in effect during the period. Translation adjustments are recorded within accumulated other comprehensive loss, a separate component of stockholders' equity, on the consolidated balance sheets. Foreign exchange transaction gains and losses have not been material to the Company's consolidated financial statements for all periods presented.


Cash and Cash Equivalents


To date, the Company invests its excess cash in money market funds. The Company considers all highly liquid financial instruments purchased with original maturities of three months or less to be cash equivalents.


Marketable Securities


The Company began investing its cash and cash equivalents in marketable securities during the fourth quarter of 2013. Marketable securities are classified as available-for-sale and have consisted of highly liquid corporate bonds, commercial paper and certificates of deposits that comply with the Company’s minimum credit rating policy. Short-term marketable securities consist of investments with final maturities of at least three months from the date of purchase that the Company intends to own for up to 12 months. Long-term marketable securities consist of investments with final maturities of more than 12 months from the date of purchase that the Company intends to own for more than 12 months, but not more than 24 months. By policy, the final maturity for each security within the portfolio shall not exceed 24 months from the date of purchase and the weighted average maturity of the portfolio shall not exceed 12 months at any point in time. Marketable securities are carried at fair value with unrealized gains and losses, net of taxes, reported as a component of stockholders’ equity on the consolidated balance sheets. See Note 4 for additional information regarding the Company’s marketable securities.


Restricted Cash


The lease agreement for the Company's New York office requires a security deposit to be maintained in the form of an unconditional, irrevocable letter of credit issued to the benefit of the landlord. The letter of credit is subject to renewal annually until the lease expires in March 2016. As of December 31, 2014 and 2013, the Company had letters of credit totaling $0.3 million included in restricted cash in the consolidated financial statements.


Concentrations and Other Risks


Financial instruments that subject the Company to a concentration of credit risk consist of cash and cash equivalents, marketable securities and accounts receivable. Cash and cash equivalents are deposited with one domestic and five foreign highly rated financial institutions and cash equivalents are invested in highly rated money market funds. Periodically, such balances may be in excess of federally insured limits. Marketable securities consist of highly liquid corporate bonds, commercial paper and certificates of deposits that comply with the Company’s minimum credit rating policy.


Except for the Company’s single largest advertising agency customer noted below, credit risk with respect to accounts receivable is dispersed due to the large number of advertising customers. Collateral is not required for accounts receivable. The Company performs ongoing credit evaluations of customers’ financial condition and periodically evaluates its outstanding accounts receivable and establishes an allowance for doubtful accounts receivable based on the Company’s historical experience, the current aging and circumstances of accounts receivable and general industry and economic conditions. Accounts receivable are written off by the Company when it has been determined that all available collection avenues have been exhausted. In 2014, bad debt write-offs totaled $0.7 million. Prior to 2014, write-offs for uncollectible accounts have not been significant. However, if circumstances change, higher than expected bad debts may result in future write-offs that are greater than the Company’s estimates.


The following table presents the changes in the allowance for doubtful accounts receivable (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Allowance for doubtful accounts receivable:

                       

Balance - beginning of period

  $ 1,056     $ 563     $ 170  

Allowance for doubtful accounts receivable

    1,154       493       393  

Doubtful accounts receivable write-offs

    (739

)

    -       -  

Balance - end of period

  $ 1,471     $ 1,056     $ 563  

The Company wrote-off $0.7 million of doubtful accounts receivable as bad debt during the year ended December 31, 2014. The Company did not write-off any doubtful accounts receivable as bad debt during the years ended December 31, 2013 and 2012.


One advertising agency customer accounted for 8%, 19% and 21% of the Company’s revenue in 2014, 2013 and 2012, respectively. The same customer accounted for 9% and 17% of the Company’s accounts receivable as of December 31, 2014 and 2013, respectively.


Property, Equipment and Software


Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, which are generally three to five years. Leasehold improvements are amortized over the shorter of the asset life or remaining lease term.


Internal-Use Software Development Costs


The Company capitalizes the costs to develop internal-use software when preliminary development efforts are successfully completed, it has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are amortized on a straight-line basis over the estimated useful life of the software, which approximates three years. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for upgrades and enhancements that are expected to result in additional material functionality are capitalized and amortized over the respective estimated useful life.


The Company capitalized $2.4 million, $2.0 million and $0.8 million of internal-use software costs during the years ended December 31, 2014, 2013 and 2012, respectively, which are included in property, equipment and software on the consolidated balance sheets. Amortization expense totaled approximately $1.1 million, $1.0 million and $0.9 million for the years ended December 31, 2014, 2013 and 2012, respectively.


Impairment of Long-lived Assets


The Company evaluates its long-lived assets for impairment when circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported as a separate caption at the lower of the carrying amount or fair value less costs to sell. There were no impairment charges recorded or changes in estimated useful lives during years ended December 31, 2014, 2013 and 2012.


Deferred Offering Costs


Deferred offering costs consisted primarily of direct incremental costs related to the Company's IPO. Upon completion of the IPO in August 2013, these amounts were offset against the proceeds of the offering. Consequently, there were no deferred offering costs included on the Company’s consolidated balance sheets as of December 31, 2013 or 2014.


Deferred Rent


The Company leases facilities worldwide under non-cancelable operating leases that expire through August 2024. These leases contain various renewal options. The Company recognizes rent holidays and escalating rent provisions on a straight-line basis over the term of the lease. The Company's deferred rent liability related to these facilities was approximately $0.3 and $0.2 million at December 31, 2014 and 2013, respectively, which are included in “Accrued liabilities” and “Other long-term liabilities” on the consolidated balance sheets.


Revenue Recognition


The Company's revenue is principally derived from advertising services measured by the number of advertising impressions displayed on digital media properties owned and controlled by third party digital media property owners and primarily priced on a cost per thousand impressions (“CPM”) basis. The Company recognizes revenue when: (1) persuasive evidence exists of an arrangement with the customer reflecting the terms and conditions under which products or services will be provided; (2) delivery has occurred or services have been provided; (3) the fee is fixed or determinable; and (4) collection is reasonably assured. For all revenue transactions, the Company considers a signed agreement, a binding insertion order or other similar documentation to be persuasive evidence of an arrangement. Arrangements for these services generally have a term of up to three months. In some cases the term may be up to one year or more.


In the normal course of business, the Company acts as a facilitator in executing transactions with third parties. The determination of whether revenue should be reported on a gross or net basis is based on an assessment of whether the Company is acting as the principal or an agent in the transaction. In determining whether the Company acts as the principal or an agent, the Company follows the accounting guidance for principal-agent considerations. While none of the factors identified in this guidance is individually considered presumptive or determinative, because the Company is the primary obligor and is responsible for (i) identifying and contracting with third party advertisers, (ii) establishing the selling prices of the advertisements sold, (iii) performing all billing and collection activities including retaining credit risk and (iv) bearing sole responsibility for fulfillment of the advertising, which may also include committing to buy advertising inventory in advance, the Company acts as the principal in these arrangements and therefore reports revenue earned and costs incurred on a gross basis.


The Company recognizes revenue based on delivery information from a combination of third party reporting and the Company's proprietary campaign tracking systems.


Multiple-element Arrangements


The Company enters into arrangements with customers to sell advertising packages that include different media placements or ad services that are delivered at the same time, or within close proximity of one another.


At the inception of an arrangement, the Company allocates arrangement consideration in multiple-deliverable revenue arrangements to all deliverables, based on the relative selling price method in accordance with the selling price hierarchy, which includes: (1) vendor-specific objective evidence (“VSOE”) if available; (2) third party evidence (“TPE”) if VSOE is not available; and (3) best estimate of selling price (“BESP”) if neither VSOE nor TPE is available.


VSOE—The Company evaluates VSOE based on its historical pricing and discounting practices for the specific product or service when sold separately. In determining VSOE, the Company requires that a substantial majority of the standalone selling prices for these services fall within a reasonably narrow pricing range. The Company historically has not entered into a large volume of single-element arrangements, so it has not been able to establish VSOE for any of its advertising products.


TPE—When VSOE cannot be established for deliverables in multiple element arrangements, the Company applies judgment with respect to whether it can establish a selling price based on TPE. TPE is determined based on competitor prices for similar deliverables when sold separately. Generally, the Company's go-to-market strategy differs from that of its peers and its offerings contain a significant level of differentiation such that the comparable pricing of services cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor services' selling prices are on a standalone basis. As a result, the Company has not been able to establish selling price based on TPE.


BESP—When the Company is unable to establish selling price using VSOE or TPE, the Company uses BESP in its allocation of arrangement consideration. The objective of BESP is to determine the price at which the Company would transact a sale if the service were sold on a standalone basis. BESP is generally used to allocate the selling price to deliverables in the Company's multiple-element arrangements. The Company determines BESP for deliverables by considering multiple factors including, but not limited to, prices it charges for similar offerings, class of advertiser, size of transaction, seasonality, observed pricing trends, available online inventory, industry pricing strategies, market conditions and competitive landscape. The Company limits the amount of allocable arrangement consideration to amounts that are fixed or determinable and that are not contingent on future performance or future deliverables. The Company periodically reviews its BESP. Changes in assumptions or judgments or changes to the elements in the arrangement could cause a material increase or decrease in the amount of revenue that the Company reports in a particular period.


The Company recognizes the relative fair value of the media placements or ad services as they are delivered assuming all other revenue recognition criteria are met. Deferred revenue is comprised of contractual billings in excess of recognized revenue and payments received in advance of revenue recognition.


Cost of revenue


Cost of revenue consists of amounts incurred with digital media property owners that are directly related to a revenue-generating event, direct labor costs, amortization of revenue-producing acquired technologies, Internet access costs and depreciation expense. The Company incurs costs with digital media property owners in the period the advertising impressions are delivered or in limited circumstances, based on minimum guaranteed number of impressions. Such amounts incurred are classified as cost of revenue in the corresponding period in which the revenue is recognized in the consolidated statements of operations.


Advertising expense


The Company's advertising costs are expensed as incurred. The Company incurred approximately $1.7 million, $1.5 million and $0.6 million in advertising expenses for the years ended December 31, 2014, 2013 and 2012, respectively.


Comprehensive Income (Loss)


Comprehensive income (loss) consists of net income (loss) and changes in accumulated other comprehensive income (loss), which are primarily the result of foreign currency translation adjustments and unrealized gains or losses on marketable securities, net of tax.


Stock-based Compensation


The Company measures compensation expense for all stock-based payment awards, including stock options granted to employees, directors and non-employees based on the estimated fair values on the date of the grant. The fair value of each stock option granted is estimated using the Black-Scholes option valuation model. Stock-based compensation expense related to restricted stock units (“RSUs”) is based on the grant date fair value of the RSUs. Stock-based compensation is recognized on a straight-line basis over the requisite service period.


Stock-based compensation expense is recorded net of estimated forfeitures in our consolidated statements of income and as such is recorded for only those share-based awards that we expect to vest. The Company estimates the forfeiture rate based on historical forfeitures of equity awards and adjusts the rate to reflect changes in facts and circumstances, if any. The Company will revise our estimated forfeiture rate if actual forfeitures differ from our initial estimates.


Goodwill


Goodwill is not amortized, but is tested for impairment at least annually or as circumstances indicate the value may no longer be recoverable. The Company evaluates goodwill for impairment annually in the fourth quarter of its fiscal year or, whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Through December 31, 2014, no impairment of goodwill has been identified.


The FASB issued an accounting standard update that permits entities to first assess qualitative factors to determine whether it is more likely than not (a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This new guidance was adopted by the Company on January 1, 2012 on a prospective basis and the adoption of did not materially impact the Company’s consolidated financial statements. As of December 31, 2014 and 2013, the Company elected to first assess qualitative factors to determine whether it is necessary to perform the two-step annual goodwill impairment test. The Company assessed qualitative factors including its market capitalization, stock price, industry and market conditions, cost factors and cash flows and concluded that it was more likely than not that the fair value of its sole reporting unit is greater than the carrying value of goodwill.


Intangible Assets


Acquired intangible assets consist of acquired customer relationships, developed technology and non-compete agreements. Acquired intangible assets are recorded at fair value, net of accumulated amortization. Intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company reviews identifiable amortizable intangible assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset over its fair value. Through December 31, 2014, no impairment of intangibles has been identified.


Preferred Stock Warrant Liability


Prior to our IPO on August 7, 2013, freestanding warrants related to shares of the Company’s preferred stock that were contingently redeemable were classified as a liability on the Company's consolidated balance sheet. The convertible preferred stock warrants were subject to re-measurement at each balance sheet date up to the date of our IPO and any changes in fair value were recognized as a component of “Other income (expense), net.” As of August 7, 2013, all redeemable convertible preferred stock warrants were converted into warrants to purchase common stock and the liability of $0.4 million was reclassified to additional paid-in capital.


Income Taxes


The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company's consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.


The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.


The Company records uncertain tax positions in accordance with accounting standards on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority.


Recently Issued Accounting Standards


In February 2013, the FASB issued Accounting Standards Updates (“ASU”) 2013-2, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU 2013-2), to improve the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-2 requires presentation, either on the face of the financial statements or in the notes, of amounts reclassified out of accumulated other comprehensive income by component and by net income line item. ASU 2013-2 is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The Company adopted ASU 2013-2 in the first quarter of fiscal 2014. The adoption of ASU 2013-2 did not have a significant impact on the Company's consolidated financial statements.


In July 2013, the FASB issued amended standards that provided explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward or a tax credit carryforward exists. The new guidance provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward, if such settlement is required or expected in the event the uncertain tax position is disallowed. The new guidance became effective on January 1, 2014 and should be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. The adoption of these amended standards did not have a significant impact on the Company’s financial position, results of operations, or cash flows.


In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount to which an entity expects to be entitled when products are transferred to customers. ASU 2014-09 will be effective for the Company beginning in its first quarter of 2017. Early adoption is not permitted. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. The Company has not yet selected a transition method and is currently evaluating the impact of adopting the new revenue standard on its consolidated financial statements.


Note 3 - Acquisitions
Business Combination Disclosure [Text Block]

3.

Acquisition


Crowd Science, Inc.


On December 28, 2012, the Company completed the acquisition of Crowd Science, Inc. (“Crowd Science”), a technology company providing online digital media properties audience measurement, ad targeting and web analytics. All of the share capital for Crowd Science was acquired in exchange for $1.1 million in cash and 2,000,000 shares of Series D-1 convertible preferred stock valued at $3.3 million, for a total consideration of $4.4 million. The Company held back $49,000 in cash and 400,000 shares of Series D-1 convertible preferred stock classified as contingent consideration to non-employee stockholders at the closing of the acquisition until the second anniversary of the closing date for general representations and warranties as well as performance conditions tied to the expected continuing employment of key employees. The goodwill generated from the Company's business combination is primarily related to expected synergies. The goodwill is deductible for U.S. federal income tax purposes.


The fair value of the Series D-1 convertible preferred stock of $1.67 per share was based on management's contemporaneous valuation of the Company as of December 28, 2012, the date of acquisition. In determining the enterprise equity value of the Company, management used a valuation methodology based on the income approach and the market approach utilizing guideline public companies. Once an enterprise equity value was calculated, management used the option pricing method to allocate the value to each series of preferred stock and common stock which generated a value of $1.67 per share of Series D-1 preferred stock.


As a condition to its acquisition of Crowd Science, the parties agreed that all amounts held back by the Company at closing, consisting of $49,000 in cash and 400,000 shares of Series D-1 convertible stock, may be permanently withheld by the Company if any key employee (identified in the acquisition agreement) were to voluntarily terminate his employment with the Company within the first year after closing of the acquisition. The performance conditions were not met during 2013. As such, the Company accounted for the settlement of this contingent consideration within equity during 2013. The Company’s 1-for-6 reverse stock split effective July 2013 and the conversion of preferred stock to common stock associated with the Company’s IPO in August 2013 resulted in the number of shares permanently held back by the Company to become 66,666 common stock shares. The Company accounts for the withheld shares as 66,666 shares of treasury stock.


The acquisition was accounted for as a business combination in accordance with ASC 805 with the results of the acquired company's operations included in the consolidated financial statements starting on December 28, 2012. The key factors underlying the acquisition were to acquire technology that would enhance audience reach and targeting across all video devices.


The aggregate purchase consideration and estimated fair values of the assets acquired and liabilities assumed at the date of acquisition were as follows (in thousands):


   

Fair Value

 

Fair value of purchase consideration:

       

Cash consideration

  $ 1,033  

Cash escrow account

    49  

2,000,000 Series D-1 preferred stock shares

    3,319  

Series D-1 issuance costs

    21  

Total purchase consideration

  $ 4,422  

   


Fair Value

 

Fair value of net assets acquired:

       

Cash

  $ 259  

Accounts receivable

    163  

Other current assets

    63  

Property and equipment

    14  

Other assets

    30  

Developed technology

    2,600  

Goodwill

    3,013  

Total assets acquired

    6,142  

Accounts payable and accruals

    461  

Deferred revenue

    223  

Deferred tax liability

    1,036  

Total liabilities assumed

    1,720  

Net assets acquired

  $ 4,422  

Details related to estimated useful lives and the valuation techniques utilized for estimating fair value of the intangible assets acquired are shown below:


Intangible Type

 

Valuation Type

 

Useful Life (years)

 

Developed Technology

 

Discounted cash flow method

    4  

The following unaudited pro forma financial information presents the results of operations of the Company and the acquired company as if the acquisition had occurred on January 1, 2011. The pro forma financial information is provided for comparative purposes only and is not necessarily indicative of what the actual results would have been had the acquisition occurred on January 1, 2011 (in thousands, except per share amounts):


   

Pro Forma for the Year Ended

December 31, 2012

 

Revenue

  $ 117,441  

Net income

  $ 2,676  

Basic and diluted net income (loss) per share attributable to common stockholders

  $ 0.00  

Note 4 - Cash, Cash Equivalents and Marketable Securities
Cash and Cash Equivalents Disclosure [Text Block]

4.

Cash, Cash Equivalents and Marketable Securities


The Company’s cash equivalents consist of highly liquid fixed-income investments with original maturities of three months or less at the time of purchase. Short- and long-term marketable securities are comprised of highly liquid available-for-sale financial instruments (primarily corporate bonds, commercial paper and certificates of deposit) with final maturities of at least three months but no more than 24 months from the date of purchase. The cost, gross unrealized gains and losses and fair value of the Company’s marketable securities consisted of the following as of December 31, 2014 and 2013 (in thousands):


   

Cost

   

Gross Unrealized Gains

   

Gross Unrealized Losses

   

Fair Value

 

December 31, 2014:

                               

Cash

  $ 26,755     $     $     $ 26,755  

Cash equivalents:

                               

Money market funds

    11,304                   11,304  

Total cash and cash equivalents

    38,059                   38,059  

Marketable securities:

                               

Corporate bonds

    28,615       1       (30

)

    28,586  

Total marketable securities

    28,615       1       (30

)

    28,586  

Total cash, cash equivalents and marketable securities

  $ 66,674     $ 1     $ (30

)

  $ 66,645  

   

Cost

   

Gross Unrealized Gains

   

Gross Unrealized Losses

   

Fair Value

 

December 31, 2013:

                               

Cash

  $ 24,255     $     $     $ 24,255  

Cash equivalents:

                               

Money market funds

    18,371                   18,371  

Total cash and cash equivalents

    42,626                   42,626  

Marketable securities:

                               

Corporate bonds

    17,892       3       (10

)

    17,885  

Commercial paper

    2,396                   2,396  

Certificates of deposit

    1,200                   1,200  

Total marketable securities

    21,488       3       (10

)

    21,481  

Total cash, cash equivalents and marketable securities

  $ 64,114     $ 3     $ (10

)

  $ 64,107  

Unrealized gains and losses, net of taxes, are included in “Accumulated other comprehensive loss,” which is reflected as a separate component of stockholders’ equity (deficit) on the consolidated balance sheets.


Note 5 - Fair Value of Financial Instruments
Fair Value Disclosures [Text Block]

5.

Fair Value of Financial Instruments


The accounting guidance for fair value measurements prioritizes the inputs used in measuring fair value in the following hierarchy:


 

Level 1 -

Unadjusted quoted prices in active markets for identical assets or liabilities;


 

Level 2 -

Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and


 

Level 3 -

Unobservable inputs for which there is little or no market data, which require the Company to develop its own assumptions.


A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The carrying amounts of accounts receivable, accounts payable and accrued liabilities, approximate fair value due to their relatively short maturities.


Prior to the conversion of the Company’s warrant liability on August 12, 2013, its preferred stock warrants were recorded at fair value. On August 12, 2013, upon the closing of the Company’s IPO, the warrants were converted from warrants to purchase preferred stock to warrants to purchase common stock and the liability at their then fair value of $0.4 million was reclassified to additional paid-in capital. Prior to this date, all changes in the fair value of the warrants were recorded in “Other income (expense), net” in the consolidated statements of operations. The fair value of the warrants outstanding, which were remeasured to fair value on a recurring basis at each balance sheet date, was determined using the Black-Scholes option pricing model. See Note 11 for additional information. The Company recorded other income of $0.1 million in both 2013 and 2012, respectively, related to the fair value adjustment of its warrants.


Marketable securities with final maturities of at least three months but no more than 12 months from the date of purchase are classified as short-term and marketable securities with final maturities of more than one year but less than two years from the date of purchase are classified as long-term. Our marketable securities are classified as available-for-sale and consist of high quality, investment grade securities from diverse issuers with predetermined minimum credit ratings. The Company values these securities based on pricing from pricing vendors who may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. However, the Company classifies all of its marketable securities as having Level 2 inputs. The valuation techniques used to measure the fair value of the Company’s marketable securities having Level 2 inputs were derived from market prices that are corroborated by observable market data and quoted market prices for similar instruments. 


The following tables present information about the Company’s money market funds and marketable securities measured at fair value on a recurring basis as of December 31, 2014 and 2013 and indicates the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value (in thousands):


   

Fair Value Measurements at December 31, 2014

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Money market funds

  $ 11,304     $ -     $ -     $ 11,304  
                                 

Marketable securities:

                               

Corporate bonds

  $ -     $ 28,586     $ -     $ 28,586  

Total marketable securities

  $ -     $ 28,586     $ -     $ 28,586  

   

Fair Value Measurements at December 31, 2013

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Money market funds

  $ 18,371     $ -     $ -     $ 18,371  
                                 

Marketable securities:

                               

Corporate bonds

  $ -     $ 17,885     $ -     $ 17,885  

Commercial paper

            2,396               2,396  

Certificates of deposit

    -       1,200       -       1,200  

Total marketable securities

  $ -     $ 21,481     $ -     $ 21,481  

The following table summarizes the changes in the warrant liability during 2013. Gains and losses reported in this table include changes in fair value that are attributable to both observable and unobservable inputs (in thousands):


   

2013

 

Beginning balance

  $ 301  

Change in fair value recorded in other income (expense), net

    125  

Reclassification of warrants to additional paid-in capital in connection with the IPO(1)

    (426

)

Ending Balance

  $ -  

 

(1)

Upon the closing of the IPO in August 2013, all outstanding warrants to purchase convertible preferred stock converted into warrants to purchase shares of common stock. Consequently, the Company reclassified the balance of these warrants to additional paid-in capital.


Note 6 - Property, Equipment, and Software
Property, Plant and Equipment Disclosure [Text Block]

6.

Property, Equipment and Software


Property, equipment and software consisted of the following (in thousands):


   

December 31,

 
   

2014

   

2013

 

Office furniture and fixtures

  $ 889     $ 494  

Equipment and computers

    10,042       7,082  

Leasehold improvements

    1,967       1,679  

Software

    1,891       1,305  

Internally developed software costs

    7,900       5,544  

Total property, equipment and software

    22,689       16,104  

Less: accumulated depreciation and amortization

    (12,282

)

    (9,494

)

Property, equipment and software, net

  $ 10,407     $ 6,610  

Depreciation and amortization expense, including amortization of internal use software costs, was approximately $3.9 million, $3.3 million and $2.6 million, for the years ended December 31, 2014, 2013 and 2012, respectively.


Assets recorded under capital leases consist primarily of data center equipment and were as follows (in thousands):


   

December 31,

 
   

2014

   

2013

 

Gross assets under capital leases

  $ 701     $ 1,910  

Less: accumulated depreciation

    (682

)

    (1,597

)

Net assets under capital leases

  $ 19     $ 313  

Note 7 - Goodwill and Intangible Assets
Goodwill and Intangible Assets Disclosure [Text Block]

7.

Goodwill and Intangible Assets


As a result of the acquisition of Appealing Media on June 15, 2011, the Company recorded the fair value of acquired intangible assets and goodwill in the amount of $0.9 million for the excess of purchase consideration over the fair value of assets and liabilities acquired. In addition, as a result of the acquisition of Crowd Science, Inc. on December 28, 2012, the Company recorded the fair value of acquired intangible assets and goodwill in the amount of $3.0 million for the excess of purchase consideration over the fair value of assets and liabilities acquired.


The intangible assets detail for the periods presented (dollars in thousands):


   

Gross Carrying Amount

   

Accumulated Amortization

   

Net Carrying

Amount

   

Weighted-Average Remaining Life (years)

 

December 31, 2014:

                               

Developed technology

  $ 2,950     $ (1,650

)

  $ 1,300    

2.0

 

Customer relationships

    104       (75

)

    29    

1.4

 

Non-compete agreement

    53       (53

)

    -    

-

 
    $ 3,107     $ (1,778

)

  $ 1,329          

   

Gross Carrying Amount

   

Accumulated Amortization

   

Net Carrying Amount

   

Weighted-Average Remaining Life (years)

 

December 31, 2013:

                               

Developed technology

  $ 2,950     $ (951

)

  $ 1,999    

2.7

 

Customer relationships

    104       (54

)

    50    

2.4

 

Non-compete agreement

    53       (53

)

    -    

-

 
    $ 3,107     $ (1,058

)

  $ 2,049          

Amortization expense for years ended December 31, 2014, 2013 and 2012 was $0.7 million, $0.8 million and $0.2 million, respectively. Amortization expense related to developed technology is included as a component of “Cost of revenue” in the consolidated statements of operations.


Estimated future amortization expense of purchased intangible assets at December 31, 2014 was as follows (in thousands):


Years ending December 31,:

 

Amount

 

2015

  $ 671  

2016

    658  

Total future amortization expense

  $ 1,329  

Note 8 - Accrued Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8.

Accrued Liabilities


Accrued liabilities consisted of the following (in thousands):


   

December 31,

 
   

2014

   

2013

 

Accrued compensation

  $ 6,884     $ 5,727  

Accrued vacation and other employee benefits

    3,761       3,081  

Accrued customer incentives

    3,884       1,540  

Accrued taxes

    47       559  

Other accrued expenses

    1,762       1,827  

Total accrued liabilities

  $ 16,338     $ 12,734  

Note 9 - Borrowings
Debt Disclosure [Text Block]

9.

Borrowings


In November 2014, the Company entered into a Loan and Security Agreement with Silicon Valley Bank (“SVB”) to borrow up to a maximum of $25.0 million collateralized by the Company’s cash deposits, accounts receivable and equipment, as well as certain other assets. The Loan and Security Agreement requires the Company to comply with certain financial and reporting covenants, including maintaining an adjusted quick ratio of 1.4 to 1.0. Annual fees under the agreement total one quarter of 1.0% of the average unused balance of the credit line per annum. As of December 31, 2014, the Company had no borrowings outstanding under this credit line.


In connection with a previous Loan and Security Agreement with SVB that expired on May 3, 2013, the Company issued warrants to SVB to purchase 29,145 shares of Series C preferred stock, of which warrants to purchase 14,573 shares were issued September 25, 2009 and warrants to purchase 14,572 shares were issued January 27, 2010. These warrants had an exercise price of $1.7155 per share. During the three months ended December 31, 2013, SVB exercised these warrants and purchased shares of the Company’s common stock.


Note 10 - Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]

10.

Commitments and Contingencies


Leases


The Company leases office facilities under various non-cancellable operating leases that expire through August 2024. Rent expense under operating leases totaled $2.7 million, $2.2 million and $1.7 million for the years ended December 31, 2014, 2013 and 2012, respectively. In addition, the Company leases certain equipment and computers under capital lease arrangements that expire at various dates through September 2015.


Purchase Commitments


During the normal course of business, to secure adequate ad inventory and impressions for its sales arrangements, the Company enters into agreements with digital media property owners that require purchase of a minimum number of impressions on a monthly or quarterly basis. Purchase commitments as of December 31, 2014 expire on various dates through December 2016.


Future Payments


Future minimum payments under these arrangements as of December 31, 2014 are as follows (in thousands):


   

Payments Due by Period

 
   

Total

   

Less Than 1 Year

   

1 - 3 Years

   

3 - 5 Years

   

More Than 5 Years

 

Operating lease obligations

  $ 8,552     $ 2,324     $ 3,794     $ 1,366     $ 1,068  

Capital lease obligations

    42       42                    

Traffic acquisition costs and other purchase commitments

    10,093       9,943       150              

Total minimum payments

  $ 18,687     $ 12,309     $ 3,944     $ 1,366     $ 1,068  

The contractual commitment amounts in the table above are associated with agreements that are enforceable and legally binding. Obligations under contracts that the Company can cancel without a significant penalty are not included in the table above. The Company has determined its uncertain tax positions as of December 31, 2014 will not result in any additional taxes payable by the Company. As a result, no amounts are shown in the table above relating to the Company’s uncertain tax positions.


Legal Proceedings


From time to time the Company may be a party to various litigation matters incidental to the conduct of its business. There is no pending or threatened legal proceeding to which the Company is currently a party that, in management’s opinion, is likely to have a material adverse effect to the Company’s consolidated financial position, results of operations, or cash flows.


Indemnification Agreements


In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of breach of such agreements, services to be provided by the Company or from intellectual property infringement claims made by third parties. In addition, the Company has entered into indemnification agreements with directors and certain officers and employees that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors, officers or employees.


While matters may arise as a result of claims under the indemnification agreements disclosed above, the Company, at this time, is not aware of claims under indemnification arrangements that could have a material adverse effect to the Company’s consolidated financial position, results of operations, or cash flows.


Note 11 - Convertible Preferred Stock and Stockholders' Equity
Stockholders' Equity Note Disclosure [Text Block]

11.

Convertible Preferred Stock and Stockholders’ Equity


Initial Public Offering


On August 12, 2013, the Company closed its IPO in which it sold 5,125,000 shares of common stock at a public offering price of $9.00 per share. The aggregate offering price for shares sold in the offering was approximately $46.1 million. Net proceeds were approximately $40.0 million, after deducting underwriting discounts and commissions of $3.2 million and offering expenses of $2.9 million.


Convertible Preferred Stock


Convertible preferred stock as of December 31, 2012 and immediately prior to the IPO consisted of the following:


Convertible Preferred Stock

 

Shares

Authorized

   

Shares Issued and

Outstanding (1)

   

Issuance Price

Per Share (1)

   

Carrying

Value (2)

   

Liquidation

Preference

 

Series A-1

    26,165,827       26,165,827     $ 0.10500     $ 1,341,000     $ 2,747,000  

Series A-2

    22,473,726       22,324,696       0.20130       4,494,000       4,494,000  

Series B

    16,134,433       16,134,433       0.54760       8,777,000       8,835,000  

Series C

    16,404,591       16,229,717       0.28592       4,546,000       4,640,000  

Series D

    24,876,609       24,876,609       1.00496       24,901,000       25,000,000  

Series D-1

    24,075,053       24,075,052       1.31370       32,132,000       31,627,000  
      130,130,239       129,806,334             $ 76,191,000     $ 77,343,000  

 

(1)

Amounts are presented without giving effect to the Company’s 1-for-6 reverse stock split that was effective July 24, 2013, as the number of convertible preferred stock shares did not change.


 

(2)

Amounts are net of issuance costs.


Balance Sheet Presentation


Upon the closing of the IPO on August 7, 2013, all outstanding shares of the Company’s convertible preferred stock automatically converted into 21,840,537 shares of common stock and the carrying value of $76.2 million is included in additional paid-in capital on the consolidated balance sheet as of December 31, 2014 and 2013.


Immediately following the closing of the IPO, the Company’s certificate of incorporation was amended to authorize 20,000,000 shares of undesignated preferred stock and 200,000,000 shares of common stock.


Preferred Stock


In association with our IPO, our board of directors authorized the Company to issue up to 20,000,000 shares of preferred stock, par value $0.001 per share. As of December 31, 2014 and 2013, no shares of preferred stock were outstanding.


Common Stock


At December 31, 2014 and 2013 there were 33,066,327 and 31,933,862 shares of common stock issued and outstanding, respectively. The following table summarizes common stock activity during the year ended December 31, 2014:


   

Number of Shares

 

Outstanding at December 31, 2013

    31,933,862  

Option exercises

    801,691  

RSUs vesting

    15,450  

Common stock issued in connection with employee stock purchase plan

    315,324  

Outstanding at December 31, 2014

    33,066,327  

Treasury Stock


The Company has 66,666 shares of treasury stock related to the acquisition of Crowd Science. Treasury stock is carried at cost and could be re-issued if the Company determined to do so. See Note 3 for additional information on Crowd Science withheld shares.


Equity Incentive Plans


The Company’s 2004 Stock Plan (the “2004 Plan”) authorized the Company to grant restricted stock awards or stock options to employees, directors and consultants at prices not less than the fair market value at date of grant for incentive stock options and not less than 85% of fair market value for non-statutory options. Option vesting schedules were determined by the board of directors at the time of issuance and they generally vest at 25% on the first anniversary of the grant (or the employment or service commencement date) and monthly over the next 36 months. Options generally expire ten years from the date of grant unless the optionee is a 10% stockholder, in which case the term will be five years from the date of grant. Unvested options exercised are subject to the Company’s repurchase right. Upon the effective date of the registration statement related to the Company’s IPO, the 2004 Plan was amended to cease the grant of any additional awards thereunder, although the Company will continue to issue common stock upon the exercise of stock options previously granted under the 2004 Plan.


In July 2013, the Company adopted a 2013 Equity Incentive Plan (the “2013 Plan”) which became effective on August 6, 2013. The 2013 Plan serves as the successor equity compensation plan to the 2004 Plan. The 2013 Plan will terminate on July 23, 2023. The 2013 Plan provides for the grant of incentive stock options, nonqualified stock options, restricted stock awards, stock appreciation rights, performance stock awards, restricted stock units and stock bonus awards to employees, directors and consultants. Stock options granted must be at prices not less than 100% of the fair market value at date of grant. Option vesting schedules are determined by the Company at the time of issuance and they generally vest at 25% on the first anniversary of the grant (or the employment or service commencement date) and monthly over the next 36 months. Options generally expire ten years from the date of grant unless the optionee is a 10% stockholder, in which case the term will be five years from the date of grant. Unvested options exercised are subject to the Company’s repurchase right. The Company initially reserved 2,000,000 shares of its common stock for issuance under the 2013 Plan, and shares reserved for issuance increase January 1 of each year by the lesser of (i) 5% of the number of shares issued and outstanding on December 31 immediately prior to the date of increase or (ii) such number of shares as may be determined by the board of directors.


Prior to the IPO, the fair value of the common stock underlying the Company’s stock options was determined by the Company’s board of directors, which intended all options granted to be exercisable at a price per share not less than the per-share fair value of the Company’s common stock underlying those options on the date of grant. The valuations of the Company’s common stock were determined in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. The assumptions the Company used in the valuation model are based on future expectations combined with management judgment. In the absence of a public trading market, the Company’s board of directors, with input from management, exercised significant judgment and considered numerous objective and subjective factors to determine the fair value of the Company’s common stock as of the date of each option grant. Subsequent to the IPO, the fair value of the common stock underlying the Company’s stock options is the closing price of the Company’s stock as of the grant date.


The following table summarizes option activity:


   

Number of Shares

(in thousands)

   

Weighted-Average Exercise Price

   

Weighted-Average Remaining Contractual Life

(years)

   

Aggregate Intrinsic Value (2)

(in thousands)

 

Balance at December 31, 2011

    4,262     $ 2.93       8.10     $ 6,906  

Granted

    913     $ 4.86                  

Exercised

    (921

)

  $ 0.78                  

Canceled and forfeited

    (239

)

  $ 4.44                  

Balance at December 31, 2012

    4,015     $ 3.78       7.88     $ 8,659  

Granted

    2,069     $ 8.58                  

Exercised

    (192

)

  $ 1.99                  

Canceled and forfeited

    (179

)

  $ 5.44                  

Balance at December 31, 2013

    5,713     $ 5.53       7.31     $ 13,704  

Granted

    783     $ 5.44                  

Exercised

    (802

)

  $ 3.79                  

Canceled and forfeited

    (635

)

  $ 7.47                  

Balance at December 31, 2014

    5,059     $ 5.54       5.78     $ 3,461  

Vested and exercisable as of December 31, 2014

    2,977     $ 4.49       5.33     $ 3,352  

Vested as of December 31, 2014 and expected to vest thereafter (1)

    4,724     $ 5.43       5.75     $ 3,454  

 

(1)

Options expected to vest reflect an estimated forfeiture rate.


 

(2)

The aggregate intrinsic value represents the difference between the Company’s estimated fair value of its common stock and the exercise price of outstanding in-the-money options as of those dates.


The weighted average grant date fair value of options granted was $3.76, $5.89 and $3.06 in 2014, 2013 and 2012, respectively. Prior to the Company’s IPO, aggregate intrinsic value represented the difference between the Company’s estimated fair value of its common stock and the exercise price of outstanding, in-the-money options. After the Company’s IPO, aggregate intrinsic value represents the difference between the market value of the Company’s common stock and the exercise price of outstanding, in-the-money options. The total intrinsic value of options exercised was approximately $2.0 million, $1.3 million and $3.4 million for 2014, 2013 and 2012, respectively.


The following table summarizes restricted stock unit activity:


   

Number of Shares (in thousands)

   

Weighted Average Fair Value at Grant

   

Weighted Average Remaining Contractual Life (years)

   

Aggregate Intrinsic Value (1) (in thousands)

 

Balance at December 31, 2012

        $              

Granted

    42     $ 8.21                  

Released

    (4

)

  $ 8.89                  

Balance at December 31, 2013

    38     $ 8.15       2.13     $ 284  

Granted

    1,202     $ 5.89                  

Released

    (15

)

  $ 7.92                  

Canceled and forfeited

    (142

)

  $ 6.05                  

Balance at December 31, 2014

    1,083     $ 5.92       1.39     $ 5,458  

 

(1)

The intrinsic value of RSUs is based on the Company’s closing stock price as reported by the New York Stock Exchange on December 31, 2013 and 2014.


The Company did not grant any RSUs prior to 2013. The total grant date fair value of restricted stock units vested during the year ended December 31, 2014 was $0.1 million. All of our RSUs that were settled during the years ended December 31, 2014 and 2013 were net share settled. As such, upon each settlement date, RSUs were withheld to cover the required withholding tax, which is based on the value of the RSU on the settlement date as determined by the closing price of our common stock on the trading day of the settlement date. The remaining amounts are delivered to the recipient as shares of our common stock.


Employee Stock Purchase Plan


In July 2013, the Company adopted a 2013 Employee Stock Purchase Plan (the “2013 Purchase Plan”) that became effective on August 6, 2013. The 2013 Purchase Plan is designed to enable eligible employees to periodically purchase shares of the Company’s common stock at a discount through payroll deductions of up to 15% of their eligible compensation, subject to any plan limitations. At the end of each offering period, employees are able to purchase shares at 85% of the lower of the fair market value of the Company’s common stock on the first trading day of the offering period or on the last day of the offering period. Purchases are accomplished through participation in discrete offering periods. The 2013 Purchase Plan is intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code. The Company initially reserved 500,000 shares of its common stock for issuance under the 2013 Purchase Plan and shares reserved for issuance increase January 1 of each year by the lesser of (i) a number of shares equal to 1% of the total number of outstanding shares of common stock on December 31 immediately prior to the date of increase or (ii) such number of shares as may be determined by the board of directors.


The expected term of ESPP shares is the average of the remaining purchase periods under each offering period. The assumptions used to value employee stock purchase rights were as follows:


   

Year Ended

December 31, 2014

   

Year Ended

December 31, 2013

 

Expected term (years)

  0.50     0.47  

Volatility

  80%     80%  

Risk-free interest rate

  0.05%-0.08%     0.08%  

Dividend yield

       

Shares Reserved for Future Issuance


At December 31, 2014 and 2013, the Company has reserved the following shares of common stock for future issuance:


   

December 31,

 
   

2014

   

2013

 

Common stock reserved:

               

Common stock options

    5,058,641       5,713,106  

Restricted stock units

    1,082,939       38,124  

Warrants to purchase common stock

    24,838       24,838  

Shares available for future issuance under the 2013 Plan

    984,455       936,457  

Employee stock purchase plan

    504,014       500,000  
      7,654,887       7,212,525  

Stock-Based Compensation


The fair value of options granted to employees is estimated on the grant date using the Black-Scholes option valuation model. This valuation model for stock-based compensation expense requires the Company to make assumptions and judgments about the variables used in the calculation including the expected term (weighted-average period of time that the options granted are expected to be outstanding), volatility of the Company’s common stock, a risk-free interest rate, expected dividends, and the estimated forfeitures of unvested stock options. To the extent actual results differ from the estimates, the difference will be recorded as a cumulative adjustment in the period estimates are revised. The Company uses the simplified calculation of expected life, and volatility is based on an average of the historical volatilities of the common stock of a group of entities with characteristics similar to those of the Company. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option. Expected forfeitures are based on the Company’s historical experience. The Company currently has no history or expectation of paying cash dividends on common stock.


The fair value of options granted to employees is determined using the Black-Scholes option valuation model with the following assumptions:


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Expected term (years)

 

6.00

   

5.51-6.12

   

5.60-6.07

 

Volatility

 

80%

   

80%

   

65% - 90%

 

Risk-free interest rate

 

1.74%-2.02%

   

1.06%-1.72%

   

0.73%-1.09%

 

Dividend yield

           

Weighted-average fair value

 

$3.76

   

$5.89

   

$3.06

 

Stock Options Granted to Non-employees


For the year ended December 31, 2012, 8,333 options were granted to non-employees. There were no options granted to non-employees during the years ended December 31, 2014 and 2013.


The Company accounts for stock options issued to non-employees in accordance with the provisions of ASC 505-50 using a fair value approach. The measurement of stock based compensation for non-employees is subject to period adjustments as the options vest and the expense is recognized over the period which services are received. The Company believes that the fair value of the stock options is more reliably measurable than the fair value of the services received. The estimated fair value of the stock options granted to non-employees was calculated using the following assumptions:


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Expected term (years)

    6.00       8.24       9.65  

Volatility

    80.0

%

    80.0

%

    80.0

%

Risk-free interest rate

    2.02

%

    2.64

%

    1.70

%

Dividend yield

                 

The following table summarizes the effects of stock-based compensation related to vesting stock-based awards included in the consolidated statements of operations (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Cost of revenue

  $ 342     $ 185     $ 128  

Sales and marketing

    2,776       1,806       1,215  

Research and development (1)

    482       346       184  

General and administrative

    2,174       1,497       515  

Total stock-based compensation

  $ 5,774     $ 3,834     $ 2,042  

 

(1)

Excludes $360,000, $226,000 and $79,000 of stock-based compensation expense that was capitalized as part of internal-use software development costs for the years ended December 31, 2014, 2013 and 2012, respectively.


No income tax benefit has been recognized relating to stock-based compensation expense and no tax benefits have been realized from exercised stock options during the years ended December 31, 2014, 2013 and 2012. As of December 31, 2014, there was $11.6 million of unrecognized compensation cost, adjusted for estimated forfeitures, related to non-vested stock-based awards which will be recognized over a weighted average period of 2.46 years. Total unrecognized compensation cost will be adjusted for future changes in estimated forfeitures. 


Warrants


In conjunction with a lease agreement, the Company issued warrants to purchase 24,838 shares of Series A-2 preferred stock on December 31, 2006. These warrants have an exercise price of $1.2078 per share and expire on December 31, 2018. On August 12, 2013, upon the closing of the Company’s IPO, the warrants were converted from warrants to purchase preferred stock to warrants to purchase common stock and the liability at their then fair value of $0.4 million was reclassified to additional paid-in capital. Prior to the conversion of the warrant liability on August 12, 2013, the Company’s preferred stock warrants were recorded at fair value. Changes in the fair value of the warrants were recorded in “Other income (expense), net” in the consolidated statements of operations. The Company recorded other expense of $0.1 million for both 2013 and 2012 related to changes in the fair value adjustment of these warrants.


The fair value of the warrants outstanding which, prior to the closing of the Company’s IPO on August 12, 2013, were recorded as liabilities on the consolidated balance sheets and which were remeasured to fair value on a recurring basis at each balance sheet date, were determined using the Black-Scholes option pricing model with the following assumptions:


   

Year 2013 through

August 12

   

Year Ended December

31, 2012

 

Expected term (years)

 

3.41-5.76

   

4.01-6.00

 

Volatility

 

80%

   

80%

 

Risk-free interest rate

 

0.47% - 1.77%

   

0.54% - 0.95%

 

Dividend yield

       

A summary of the fair value of the warrants outstanding at December 31, 2012 and immediately prior to the closing of the Company’s IPO on August 12, 2013 are shown in the table below (in thousands):


   

August 12,

2013

   

December 31,

2012

 

Warrant (series A-2)

  $ 203     $ 144  

Warrant (series C)

    223       157  

Total fair value

  $ 426     $ 301  

The change in total fair value of the convertible preferred stock warrants has been recorded as a component of “Other income (expense)” in the consolidated statements of operations. After the warrants were converted into warrants for common stock in association with the completion of the Company’s IPO in August 2013, the total fair value of the warrants is no longer subject to remeasurement.


A summary of the warrants to purchase common stock outstanding at December 31, 2014 and 2013 are shown below:


Issue Date

 

Security

 

Expiration

 

Exercise Price

   

Number of Shares under Warrants

 

December 31, 2006

 

Common Stock

 

December 31, 2018

  $ 1.2078       24,838  

Note 12 - Net Income (Loss) Per Share
Earnings Per Share [Text Block]

12.

Net Income (Loss) per Share


Basic and diluted net income (loss) per common share is presented in conformity with the two-class method required for participating securities. Immediately prior to the closing of the Company’s IPO, all shares of outstanding convertible preferred stock automatically converted into shares of the Company’s common stock. Prior to the conversion of the convertible preferred stock, holders of Series A-1, Series A-2, Series B, Series C, Series D and Series D-1 convertible preferred stock were entitled to receive noncumulative dividends when and if declared at the annual rate of 8% ($0.10500, $0.20130, $0.54760, $0.28592, $1.00496 and $1.31370 per share per annum, respectively) payable prior, and in preference to, any dividends on any shares of the Company’s common stock. In the event a dividend was paid on common stock, the holders of Series A-1, Series A-2, Series B, Series C, Series D and Series D-1 convertible preferred stock were entitled to a proportionate share of any such dividend as if they were holders of common stock (on an as-if converted basis). The holders of convertible preferred stock did not have a contractual obligation to share in the losses of the Company, accordingly, basic and diluted net income (loss) per share has not been computed using the two class method.


Under the two-class method, net income (loss) attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income (loss) less current period convertible preferred stock non-cumulative dividends, between common stock and convertible preferred stock. In computing diluted net income (loss) attributable to common stockholders, undistributed earnings are re-allocated to reflect the potential impact of dilutive securities. Basic net income (loss) per common share is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share attributable to common stockholders is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding, including potential dilutive common shares assuming the dilutive effect of outstanding stock options using the treasury stock method.


The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except per share data):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Numerator:

                       

Net income (loss)

  $ (8,745

)

  $ 321     $ 6,266  

Less: Undistributed earnings allocated to participating securities

                (6,177

)

Net income (loss) attributable to common stockholders

  $ (8,745

)

  $ 321     $ 89  
                         

Denominator:

                       

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:

                       

Basic

    32,591       15,752       4,716  

Weighted-average effect of potentially dilutive shares:

                       

Employee stock options and restricted stock units

          1,459       790  

Convertible preferred, common stock warrants and employee stock purchase plan

          39       39  

Diluted

    32,591       17,250       5,545  

Net income (loss) per share attributable to common stockholders:

                       

Basic

  $ (0.27

)

  $ 0.02     $ 0.02  

Diluted

  $ (0.27

)

  $ 0.02     $ 0.02  

The following equity shares were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders because their effect would have been anti-dilutive for the periods presented (in thousands):


   

As of December 31,

 
   

2014

   

2013

   

2012

 

Convertible preferred stock

                21,634  

Employee stock options and restricted stock units

    5,944       1,280       205  

Warrants to purchase common stock

    25              

Note 13 - Income Taxes
Income Tax Disclosure [Text Block]

13.

Income Taxes


The Company accounts for income taxes in accordance with authoritative guidance, which requires the use of the asset and liability method. Under this method, deferred income tax assets and liabilities are determined based upon the difference between the consolidated financial statement carrying amounts and the tax basis of assets and liabilities and are measured using the enacted tax rate expected to apply to taxable income in the years in which the differences are expected to be reversed.


The following table presents domestic and foreign components of income (loss) before income taxes for the periods presented (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Domestic

  $ (9,899

)

  $ 369     $ 6,289  

Foreign

    930       622       589  

Total

  $ (8,969

)

  $ 991     $ 6,878  

The components of income tax (expense) benefit are as follows (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Current:

                       

Federal

  $ 21     $ (106

)

  $ (220

)

State

    270       (493

)

    (190

)

Foreign

    (403

)

    (260

)

    (146

)

Total

    (112

)

    (859

)

    (556

)

Deferred:

                       

Federal

    221       221        

State

    105       23        

Foreign

    10       (55

)

    (56

)

Total

    336       189       (56

)

Total income tax (expense) benefit

  $ 224     $ (670

)

  $ (612

)


The primary differences between the effective tax rates and the federal statutory tax rate relates to the valuation allowances on the Company's net operating losses, state income taxes, foreign tax rate differences and non-deductible stock-based compensation expense. The following table presents a reconciliation of the statutory federal rate and the Company's effective tax rate for the periods presented:


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Tax benefit at federal statutory rate

    34.0

%

    34.0

%

    34.0

%

State, net of federal effect

    4.2       31.3       1.8  

Foreign rate differential

    3.5       (21.4

)

    (2.9

)

Stock-based compensation

    (9.7

)

    76.5       7.2  

Change in valuation allowance

    (28.8

)

    (51.4

)

    (46.7

)

Other non-deductible expenses

    (0.6

)

    (1.2

)

    8.0  

Other

    (0.1     (0.2

)

    7.5  

Total provision

    2.5

%

    67.6

%

    8.9

%


Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The following table presents the significant components of the Company's deferred tax assets and liabilities for the periods presented (in thousands):


   

December 31,

 
   

2014

   

2013

 

Deferred tax assets:

               

Accruals and reserves

  $ 1,563     $ 1,314  

Net operating loss carryforwards

    4,604       4,307  

Tax credit carryforwards

    1,476       1,234  

Stock-based compensation

    2,600       1,977  

Foreign taxes

    38       19  

Total deferred tax assets

    10,281       8,851  
                 

Fixed assets

    (512

)

    (283

)

State taxes

    (578

)

    (1,025

)

Purchased intangible assets

    (465

)

    (792

)

Total deferred tax liabilities

    (1,555

)

    (2,100

)

                 

Valuation allowance

    (9,157

)

    (7,524

)

Total net deferred tax liabilities

  $ (431

)

  $ (773

)


A valuation allowance is provided when it is more likely than not that the deferred tax assets will not be realized. As of December 31, 2014 and December 31, 2013, a full valuation allowance on domestic deferred tax assets was placed due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets. The Company’s valuation allowance as of December 31, 2014, 2013 and 2012 was attributable to the uncertainty of realizing future tax benefits from U.S. net operating losses, foreign timing differences and other deferred tax assets. The Company’s valuation allowance increased $1.6 million and $0.1 million in the years ended December 31, 2014 and 2013, respectively, and decreased $2.7 million in the year ended December 31, 2012.


As of December 31, 2014, the Company has U.S. federal net operating loss carryforwards of approximately $9.5 million, expiring beginning in 2026. As of December 31, 2014, the Company has U.S. state and local net operating loss carryforwards of approximately $15.9 million, expiring beginning in 2016.


As of December 31, 2014, the Company has federal research and development tax credits of approximately $0.8 million, which expire beginning in 2026. As of December 31, 2014, the Company has state research and development tax credits of approximately $0.7 million, and other tax credits of approximately $0.3 million, both of which carry forward indefinitely.


Internal Revenue Code section 382 places a limitation (the “Section 382 Limitation”) on the amount of taxable income that can be offset by net operating carryforwards after a change in control of a loss corporation. Generally, after a change in control, a loss corporation cannot deduct operating loss carryovers in excess of the Section 382 Limitation. Management has determined that any limitation imposed by Section 382 will not have significant impact on the utilization of its net operating loss and credit carryforwards against taxable income in future periods.


U.S. income and foreign withholding taxes associated with the repatriation of earnings of foreign subsidiaries have not been provided on undistributed earnings of foreign subsidiaries. The Company intends to reinvest theses earnings indefinitely outside the United States. If these earnings were distributed to the U.S. in the form of dividends or otherwise, or if the shares of the relevant subsidiaries were sold or otherwise transferred, the Company may be subject to additional U.S. income taxes (subject to an adjustment for foreign tax credits) and foreign withholding taxes; however, the determination of such amount is not practicable. As of December 31, 2014, the cumulative amount of earnings upon which U.S. income taxes have not been provided for is approximately $1.5 million.


Uncertain Tax Positions


A reconciliation of the beginning and ending balances of the unrecognized tax benefits during the years ended December 31, 2014, 2013 and 2012 consist of the following (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Unrecognized benefit - beginning of period

  $ 358     $ 246     $ 158  

Gross increases - current year tax provisions

    101       112       88  

Unrecognized benefit - end of period

  $ 459     $ 358     $ 246  

The entire amount of any unrecognized tax benefits would not impact the Company’s effective tax rate if recognized.


Accrued interest and penalties related to unrecognized tax benefits are classified as income tax expense and were immaterial. The Company files income tax returns in the United States, various states and certain foreign jurisdictions. The tax periods 2010 through 2013 remain open in most jurisdictions. In addition, any tax losses and research and development credit carryforwards that were generated in prior years and carried forward may also be subject to examination by respective taxing authorities. The Company is not currently under examination by income tax authorities in federal, state or other foreign jurisdictions.


Note 15 - Segments
Segment Reporting Disclosure [Text Block]

15.

Segments and Geographical Information


The Company considers operating segments to be components of the Company in which separate financial information is available that is reviewed regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in evaluating performance. The chief operating decision maker for the Company is the Chief Executive Officer who reviews financial information at a consolidated level for purposes of allocating resources and evaluating financial performance. The Company has only one business activity and one operating and reporting segment. There are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated level. The following table summarizes total revenue generated through sales personnel employed in the respective locations (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Domestic

  $ 149,617     $ 134,846     $ 110,872  

International

    28,162       16,282       5,872  

Total revenue

  $ 177,779     $ 151,128     $ 116,744  

The Company’s long-lived assets are primarily located in the United States.


Accounting Policies, by Policy (Policies)

Basis of Presentation


The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”).


In July 2013, the Company's board of directors and stockholders approved an amendment to the amended and restated certificate of incorporation. The amendment provided for a 1-for-6 reverse stock split of the outstanding common stock, effective July 24, 2013. Accordingly, (i) every six shares of common stock were combined into one share of common stock, (ii) the number of shares of common stock into which each outstanding option or warrant to purchase common stock is exercisable, as the case may be, have been proportionately decreased on a 1-for-6 basis, (iii) the exercise price for each such outstanding option or warrant to purchase common stock has been proportionately increased on a 6-for-1 basis, and (iv) the conversion ratio for each share of preferred stock outstanding was proportionately reduced on a 1-for-6 basis. All of the share numbers, share prices, and exercise prices have been adjusted within these financial statements, on a retroactive basis, to reflect this 1-for-6 reverse stock split. The Company paid cash in lieu of any fractional shares to which a holder of common stock would otherwise be entitled as a result of the reverse stock split.


On August 12, 2013, the Company closed the IPO of its common stock pursuant to a registration statement on Form S-1. In the IPO, the Company sold 5,125,000 shares of common stock at a public offering price of $9.00 per share. Net proceeds were approximately $40.0 million, after deducting underwriting discounts and commissions of $3.2 million and offering expenses of $2.9 million. Upon the closing of the IPO, all outstanding shares of the Company’s convertible preferred stock automatically converted into 21,840,537 shares of common stock and all outstanding warrants to purchase convertible preferred stock converted into warrants to purchase 53,983 shares of common stock.

Basis of Consolidation


The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Concentrations and Other Risks


Financial instruments that subject the Company to a concentration of credit risk consist of cash and cash equivalents, marketable securities and accounts receivable. Cash and cash equivalents are deposited with one domestic and five foreign highly rated financial institutions and cash equivalents are invested in highly rated money market funds. Periodically, such balances may be in excess of federally insured limits. Marketable securities consist of highly liquid corporate bonds, commercial paper and certificates of deposits that comply with the Company’s minimum credit rating policy.


Except for the Company’s single largest advertising agency customer noted below, credit risk with respect to accounts receivable is dispersed due to the large number of advertising customers. Collateral is not required for accounts receivable. The Company performs ongoing credit evaluations of customers’ financial condition and periodically evaluates its outstanding accounts receivable and establishes an allowance for doubtful accounts receivable based on the Company’s historical experience, the current aging and circumstances of accounts receivable and general industry and economic conditions. Accounts receivable are written off by the Company when it has been determined that all available collection avenues have been exhausted. In 2014, bad debt write-offs totaled $0.7 million. Prior to 2014, write-offs for uncollectible accounts have not been significant. However, if circumstances change, higher than expected bad debts may result in future write-offs that are greater than the Company’s estimates.


The following table presents the changes in the allowance for doubtful accounts receivable (in thousands):


   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Allowance for doubtful accounts receivable:

                       

Balance - beginning of period

  $ 1,056     $ 563     $ 170  

Allowance for doubtful accounts receivable

    1,154       493       393  

Doubtful accounts receivable write-offs

    (739

)

    -       -  

Balance - end of period

  $ 1,471     $ 1,056     $ 563  

The Company wrote-off $0.7 million of doubtful accounts receivable as bad debt during the year ended December 31, 2014. The Company did not write-off any doubtful accounts receivable as bad debt during the years ended December 31, 2013 and 2012.


One advertising agency customer accounted for 8%, 19% and 21% of the Company’s revenue in 2014, 2013 and 2012, respectively. The same customer accounted for 9% and 17% of the Company’s accounts receivable as of December 31, 2014 and 2013, respectively.

Use of Estimates


The preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of income and expenses during the reporting period. These estimates are based on information available as of the date of the financial statements; therefore, actual results could differ from management's estimates.

Foreign Currency Translation and Transactions


The consolidated financial statements of the Company's foreign subsidiaries are measured using the local currency as the functional currency, except for India and France, which have U.S. dollar and British pound sterling functional currencies, respectively. Assets and liabilities of foreign subsidiaries are translated at exchange rates in effect as of the balance sheet date. Revenues and expenses are translated at average exchanges rates in effect during the period. Translation adjustments are recorded within accumulated other comprehensive loss, a separate component of stockholders' equity, on the consolidated balance sheets. Foreign exchange transaction gains and losses have not been material to the Company's consolidated financial statements for all periods presented.

Cash and Cash Equivalents


To date, the Company invests its excess cash in money market funds. The Company considers all highly liquid financial instruments purchased with original maturities of three months or less to be cash equivalents.

Marketable Securities


The Company began investing its cash and cash equivalents in marketable securities during the fourth quarter of 2013. Marketable securities are classified as available-for-sale and have consisted of highly liquid corporate bonds, commercial paper and certificates of deposits that comply with the Company’s minimum credit rating policy. Short-term marketable securities consist of investments with final maturities of at least three months from the date of purchase that the Company intends to own for up to 12 months. Long-term marketable securities consist of investments with final maturities of more than 12 months from the date of purchase that the Company intends to own for more than 12 months, but not more than 24 months. By policy, the final maturity for each security within the portfolio shall not exceed 24 months from the date of purchase and the weighted average maturity of the portfolio shall not exceed 12 months at any point in time. Marketable securities are carried at fair value with unrealized gains and losses, net of taxes, reported as a component of stockholders’ equity on the consolidated balance sheets. See Note 4 for additional information regarding the Company’s marketable securities.

Restricted Cash


The lease agreement for the Company's New York office requires a security deposit to be maintained in the form of an unconditional, irrevocable letter of credit issued to the benefit of the landlord. The letter of credit is subject to renewal annually until the lease expires in March 2016. As of December 31, 2014 and 2013, the Company had letters of credit totaling $0.3 million included in restricted cash in the consolidated financial statements.

Property, Equipment and Software


Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets, which are generally three to five years. Leasehold improvements are amortized over the shorter of the asset life or remaining lease term.

Internal-Use Software Development Costs


The Company capitalizes the costs to develop internal-use software when preliminary development efforts are successfully completed, it has authorized and committed project funding, and it is probable that the project will be completed and the software will be used as intended. Such costs are amortized on a straight-line basis over the estimated useful life of the software, which approximates three years. Costs incurred prior to meeting these criteria, together with costs incurred for training and maintenance, are expensed as incurred. Costs incurred for upgrades and enhancements that are expected to result in additional material functionality are capitalized and amortized over the respective estimated useful life.


The Company capitalized $2.4 million, $2.0 million and $0.8 million of internal-use software costs during the years ended December 31, 2014, 2013 and 2012, respectively, which are included in property, equipment and software on the consolidated balance sheets. Amortization expense totaled approximately $1.1 million, $1.0 million and $0.9 million for the years ended December 31, 2014, 2013 and 2012, respectively.

Impairment of Long-lived Assets


The Company evaluates its long-lived assets for impairment when circumstances indicate the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported as a separate caption at the lower of the carrying amount or fair value less costs to sell. There were no impairment charges recorded or changes in estimated useful lives during years ended December 31, 2014, 2013 and 2012.

Deferred Offering Costs


Deferred offering costs consisted primarily of direct incremental costs related to the Company's IPO. Upon completion of the IPO in August 2013, these amounts were offset against the proceeds of the offering. Consequently, there were no deferred offering costs included on the Company’s consolidated balance sheets as of December 31, 2013 or 2014.

Deferred Rent


The Company leases facilities worldwide under non-cancelable operating leases that expire through August 2024. These leases contain various renewal options. The Company recognizes rent holidays and escalating rent provisions on a straight-line basis over the term of the lease. The Company's deferred rent liability related to these facilities was approximately $0.3 and $0.2 million at December 31, 2014 and 2013, respectively, which are included in “Accrued liabilities” and “Other long-term liabilities” on the consolidated balance sheets.

Revenue Recognition


The Company's revenue is principally derived from advertising services measured by the number of advertising impressions displayed on digital media properties owned and controlled by third party digital media property owners and primarily priced on a cost per thousand impressions (“CPM”) basis. The Company recognizes revenue when: (1) persuasive evidence exists of an arrangement with the customer reflecting the terms and conditions under which products or services will be provided; (2) delivery has occurred or services have been provided; (3) the fee is fixed or determinable; and (4) collection is reasonably assured. For all revenue transactions, the Company considers a signed agreement, a binding insertion order or other similar documentation to be persuasive evidence of an arrangement. Arrangements for these services generally have a term of up to three months. In some cases the term may be up to one year or more.


In the normal course of business, the Company acts as a facilitator in executing transactions with third parties. The determination of whether revenue should be reported on a gross or net basis is based on an assessment of whether the Company is acting as the principal or an agent in the transaction. In determining whether the Company acts as the principal or an agent, the Company follows the accounting guidance for principal-agent considerations. While none of the factors identified in this guidance is individually considered presumptive or determinative, because the Company is the primary obligor and is responsible for (i) identifying and contracting with third party advertisers, (ii) establishing the selling prices of the advertisements sold, (iii) performing all billing and collection activities including retaining credit risk and (iv) bearing sole responsibility for fulfillment of the advertising, which may also include committing to buy advertising inventory in advance, the Company acts as the principal in these arrangements and therefore reports revenue earned and costs incurred on a gross basis.


The Company recognizes revenue based on delivery information from a combination of third party reporting and the Company's proprietary campaign tracking systems.

Multiple-element Arrangements


The Company enters into arrangements with customers to sell advertising packages that include different media placements or ad services that are delivered at the same time, or within close proximity of one another.


At the inception of an arrangement, the Company allocates arrangement consideration in multiple-deliverable revenue arrangements to all deliverables, based on the relative selling price method in accordance with the selling price hierarchy, which includes: (1) vendor-specific objective evidence (“VSOE”) if available; (2) third party evidence (“TPE”) if VSOE is not available; and (3) best estimate of selling price (“BESP”) if neither VSOE nor TPE is available.


VSOE—The Company evaluates VSOE based on its historical pricing and discounting practices for the specific product or service when sold separately. In determining VSOE, the Company requires that a substantial majority of the standalone selling prices for these services fall within a reasonably narrow pricing range. The Company historically has not entered into a large volume of single-element arrangements, so it has not been able to establish VSOE for any of its advertising products.


TPE—When VSOE cannot be established for deliverables in multiple element arrangements, the Company applies judgment with respect to whether it can establish a selling price based on TPE. TPE is determined based on competitor prices for similar deliverables when sold separately. Generally, the Company's go-to-market strategy differs from that of its peers and its offerings contain a significant level of differentiation such that the comparable pricing of services cannot be obtained. Furthermore, the Company is unable to reliably determine what similar competitor services' selling prices are on a standalone basis. As a result, the Company has not been able to establish selling price based on TPE.


BESP—When the Company is unable to establish selling price using VSOE or TPE, the Company uses BESP in its allocation of arrangement consideration. The objective of BESP is to determine the price at which the Company would transact a sale if the service were sold on a standalone basis. BESP is generally used to allocate the selling price to deliverables in the Company's multiple-element arrangements. The Company determines BESP for deliverables by considering multiple factors including, but not limited to, prices it charges for similar offerings, class of advertiser, size of transaction, seasonality, observed pricing trends, available online inventory, industry pricing strategies, market conditions and competitive landscape. The Company limits the amount of allocable arrangement consideration to amounts that are fixed or determinable and that are not contingent on future performance or future deliverables. The Company periodically reviews its BESP. Changes in assumptions or judgments or changes to the elements in the arrangement could cause a material increase or decrease in the amount of revenue that the Company reports in a particular period.


The Company recognizes the relative fair value of the media placements or ad services as they are delivered assuming all other revenue recognition criteria are met. Deferred revenue is comprised of contractual billings in excess of recognized revenue and payments received in advance of revenue recognition.

Cost of revenue


Cost of revenue consists of amounts incurred with digital media property owners that are directly related to a revenue-generating event, direct labor costs, amortization of revenue-producing acquired technologies, Internet access costs and depreciation expense. The Company incurs costs with digital media property owners in the period the advertising impressions are delivered or in limited circumstances, based on minimum guaranteed number of impressions. Such amounts incurred are classified as cost of revenue in the corresponding period in which the revenue is recognized in the consolidated statements of operations.

Advertising expense


The Company's advertising costs are expensed as incurred. The Company incurred approximately $1.7 million, $1.5 million and $0.6 million in advertising expenses for the years ended December 31, 2014, 2013 and 2012, respectively.

Comprehensive Income (Loss)


Comprehensive income (loss) consists of net income (loss) and changes in accumulated other comprehensive income (loss), which are primarily the result of foreign currency translation adjustments and unrealized gains or losses on marketable securities, net of tax.

Stock-based Compensation


The Company measures compensation expense for all stock-based payment awards, including stock options granted to employees, directors and non-employees based on the estimated fair values on the date of the grant. The fair value of each stock option granted is estimated using the Black-Scholes option valuation model. Stock-based compensation expense related to restricted stock units (“RSUs”) is based on the grant date fair value of the RSUs. Stock-based compensation is recognized on a straight-line basis over the requisite service period.


Stock-based compensation expense is recorded net of estimated forfeitures in our consolidated statements of income and as such is recorded for only those share-based awards that we expect to vest. The Company estimates the forfeiture rate based on historical forfeitures of equity awards and adjusts the rate to reflect changes in facts and circumstances, if any. The Company will revise our estimated forfeiture rate if actual forfeitures differ from our initial estimates.

Goodwill


Goodwill is not amortized, but is tested for impairment at least annually or as circumstances indicate the value may no longer be recoverable. The Company evaluates goodwill for impairment annually in the fourth quarter of its fiscal year or, whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Through December 31, 2014, no impairment of goodwill has been identified.


The FASB issued an accounting standard update that permits entities to first assess qualitative factors to determine whether it is more likely than not (a likelihood of more than 50%) that the fair value of a reporting unit is less than its carrying amount as a basis for determining whether it is necessary to perform the two-step goodwill impairment test. This new guidance was adopted by the Company on January 1, 2012 on a prospective basis and the adoption of did not materially impact the Company’s consolidated financial statements. As of December 31, 2014 and 2013, the Company elected to first assess qualitative factors to determine whether it is necessary to perform the two-step annual goodwill impairment test. The Company assessed qualitative factors including its market capitalization, stock price, industry and market conditions, cost factors and cash flows and concluded that it was more likely than not that the fair value of its sole reporting unit is greater than the carrying value of goodwill.

Intangible Assets


Acquired intangible assets consist of acquired customer relationships, developed technology and non-compete agreements. Acquired intangible assets are recorded at fair value, net of accumulated amortization. Intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company reviews identifiable amortizable intangible assets to be held and used for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset over its fair value. Through December 31, 2014, no impairment of intangibles has been identified.

Preferred Stock Warrant Liability


Prior to our IPO on August 7, 2013, freestanding warrants related to shares of the Company’s preferred stock that were contingently redeemable were classified as a liability on the Company's consolidated balance sheet. The convertible preferred stock warrants were subject to re-measurement at each balance sheet date up to the date of our IPO and any changes in fair value were recognized as a component of “Other income (expense), net.” As of August 7, 2013, all redeemable convertible preferred stock warrants were converted into warrants to purchase common stock and the liability of $0.4 million was reclassified to additional paid-in capital.

Income Taxes


The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company's consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.


The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.


The Company records uncertain tax positions in accordance with accounting standards on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority.

Recently Issued Accounting Standards


In February 2013, the FASB issued Accounting Standards Updates (“ASU”) 2013-2, Comprehensive Income (Topic 220): Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income (ASU 2013-2), to improve the reporting of reclassifications out of accumulated other comprehensive income. ASU 2013-2 requires presentation, either on the face of the financial statements or in the notes, of amounts reclassified out of accumulated other comprehensive income by component and by net income line item. ASU 2013-2 is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2012. The Company adopted ASU 2013-2 in the first quarter of fiscal 2014. The adoption of ASU 2013-2 did not have a significant impact on the Company's consolidated financial statements.


In July 2013, the FASB issued amended standards that provided explicit guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward or a tax credit carryforward exists. The new guidance provides that a liability related to an unrecognized tax benefit would be presented as a reduction of a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward, if such settlement is required or expected in the event the uncertain tax position is disallowed. The new guidance became effective on January 1, 2014 and should be applied prospectively to unrecognized tax benefits that exist at the effective date with retrospective application permitted. The adoption of these amended standards did not have a significant impact on the Company’s financial position, results of operations, or cash flows.


In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which amends the existing accounting standards for revenue recognition. ASU 2014-09 is based on principles that govern the recognition of revenue at an amount to which an entity expects to be entitled when products are transferred to customers. ASU 2014-09 will be effective for the Company beginning in its first quarter of 2017. Early adoption is not permitted. The new revenue standard may be applied retrospectively to each prior period presented or retrospectively with the cumulative effect recognized as of the date of adoption. The Company has not yet selected a transition method and is currently evaluating the impact of adopting the new revenue standard on its consolidated financial statements.

Note 2 - Summary of Significant Accounting Policies (Tables)
Allowance for Credit Losses on Financing Receivables [Table Text Block]
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Allowance for doubtful accounts receivable:

                       

Balance - beginning of period

  $ 1,056     $ 563     $ 170  

Allowance for doubtful accounts receivable

    1,154       493       393  

Doubtful accounts receivable write-offs

    (739

)

    -       -  

Balance - end of period

  $ 1,471     $ 1,056     $ 563  
Note 3 - Acquisitions (Tables)
   

Fair Value

 

Fair value of purchase consideration:

       

Cash consideration

  $ 1,033  

Cash escrow account

    49  

2,000,000 Series D-1 preferred stock shares

    3,319  

Series D-1 issuance costs

    21  

Total purchase consideration

  $ 4,422  
   


Fair Value

 

Fair value of net assets acquired:

       

Cash

  $ 259  

Accounts receivable

    163  

Other current assets

    63  

Property and equipment

    14  

Other assets

    30  

Developed technology

    2,600  

Goodwill

    3,013  

Total assets acquired

    6,142  

Accounts payable and accruals

    461  

Deferred revenue

    223  

Deferred tax liability

    1,036  

Total liabilities assumed

    1,720  

Net assets acquired

  $ 4,422  

Intangible Type

 

Valuation Type

 

Useful Life (years)

 

Developed Technology

 

Discounted cash flow method

    4  
   

Pro Forma for the Year Ended

December 31, 2012

 

Revenue

  $ 117,441  

Net income

  $ 2,676  

Basic and diluted net income (loss) per share attributable to common stockholders

  $ 0.00  
Note 4 - Cash, Cash Equivalents and Marketable Securities (Tables)
Cash, Cash Equivalents and Investments [Table Text Block]
   

Cost

   

Gross Unrealized Gains

   

Gross Unrealized Losses

   

Fair Value

 

December 31, 2014:

                               

Cash

  $ 26,755     $     $     $ 26,755  

Cash equivalents:

                               

Money market funds

    11,304                   11,304  

Total cash and cash equivalents

    38,059                   38,059  

Marketable securities:

                               

Corporate bonds

    28,615       1       (30

)

    28,586  

Total marketable securities

    28,615       1       (30

)

    28,586  

Total cash, cash equivalents and marketable securities

  $ 66,674     $ 1     $ (30

)

  $ 66,645  
   

Cost

   

Gross Unrealized Gains

   

Gross Unrealized Losses

   

Fair Value

 

December 31, 2013:

                               

Cash

  $ 24,255     $     $     $ 24,255  

Cash equivalents:

                               

Money market funds

    18,371                   18,371  

Total cash and cash equivalents

    42,626                   42,626  

Marketable securities:

                               

Corporate bonds

    17,892       3       (10

)

    17,885  

Commercial paper

    2,396                   2,396  

Certificates of deposit

    1,200                   1,200  

Total marketable securities

    21,488       3       (10

)

    21,481  

Total cash, cash equivalents and marketable securities

  $ 64,114     $ 3     $ (10

)

  $ 64,107  
Note 5 - Fair Value of Financial Instruments (Tables)
   

Fair Value Measurements at December 31, 2014

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Money market funds

  $ 11,304     $ -     $ -     $ 11,304  
                                 

Marketable securities:

                               

Corporate bonds

  $ -     $ 28,586     $ -     $ 28,586  

Total marketable securities

  $ -     $ 28,586     $ -     $ 28,586  
   

Fair Value Measurements at December 31, 2013

 
   

Level 1

   

Level 2

   

Level 3

   

Total

 

Money market funds

  $ 18,371     $ -     $ -     $ 18,371  
                                 

Marketable securities:

                               

Corporate bonds

  $ -     $ 17,885     $ -     $ 17,885  

Commercial paper

            2,396               2,396  

Certificates of deposit

    -       1,200       -       1,200  

Total marketable securities

  $ -     $ 21,481     $ -     $ 21,481  
   

2013

 

Beginning balance

  $ 301  

Change in fair value recorded in other income (expense), net

    125  

Reclassification of warrants to additional paid-in capital in connection with the IPO(1)

    (426

)

Ending Balance

  $ -  
Note 6 - Property, Equipment, and Software (Tables)
   

December 31,

 
   

2014

   

2013

 

Office furniture and fixtures

  $ 889     $ 494  

Equipment and computers

    10,042       7,082  

Leasehold improvements

    1,967       1,679  

Software

    1,891       1,305  

Internally developed software costs

    7,900       5,544  

Total property, equipment and software

    22,689       16,104  

Less: accumulated depreciation and amortization

    (12,282

)

    (9,494

)

Property, equipment and software, net

  $ 10,407     $ 6,610  
   

December 31,

 
   

2014

   

2013

 

Gross assets under capital leases

  $ 701     $ 1,910  

Less: accumulated depreciation

    (682

)

    (1,597

)

Net assets under capital leases

  $ 19     $ 313  
Note 7 - Goodwill and Intangible Assets (Tables)
   

Gross Carrying Amount

   

Accumulated Amortization

   

Net Carrying

Amount

   

Weighted-Average Remaining Life (years)

 

December 31, 2014:

                               

Developed technology

  $ 2,950     $ (1,650

)

  $ 1,300    

2.0

 

Customer relationships

    104       (75

)

    29    

1.4

 

Non-compete agreement

    53       (53

)

    -    

-

 
    $ 3,107     $ (1,778

)

  $ 1,329          
   

Gross Carrying Amount

   

Accumulated Amortization

   

Net Carrying Amount

   

Weighted-Average Remaining Life (years)

 

December 31, 2013:

                               

Developed technology

  $ 2,950     $ (951

)

  $ 1,999    

2.7

 

Customer relationships

    104       (54

)

    50    

2.4

 

Non-compete agreement

    53       (53

)

    -    

-

 
    $ 3,107     $ (1,058

)

  $ 2,049          

Years ending December 31,:

 

Amount

 

2015

  $ 671  

2016

    658  

Total future amortization expense

  $ 1,329  
Note 8 - Accrued Liabilities (Tables)
Schedule of Accrued Liabilities [Table Text Block]
   

December 31,

 
   

2014

   

2013

 

Accrued compensation

  $ 6,884     $ 5,727  

Accrued vacation and other employee benefits

    3,761       3,081  

Accrued customer incentives

    3,884       1,540  

Accrued taxes

    47       559  

Other accrued expenses

    1,762       1,827  

Total accrued liabilities

  $ 16,338     $ 12,734  
Note 10 - Commitments and Contingencies (Tables)
Contractual Obligation, Fiscal Year Maturity Schedule [Table Text Block]
   

Payments Due by Period

 
   

Total

   

Less Than 1 Year

   

1 - 3 Years

   

3 - 5 Years

   

More Than 5 Years

 

Operating lease obligations

  $ 8,552     $ 2,324     $ 3,794     $ 1,366     $ 1,068  

Capital lease obligations

    42       42                    

Traffic acquisition costs and other purchase commitments

    10,093       9,943       150              

Total minimum payments

  $ 18,687     $ 12,309     $ 3,944     $ 1,366     $ 1,068  
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Tables)

Convertible Preferred Stock

 

Shares

Authorized

   

Shares Issued and

Outstanding (1)

   

Issuance Price

Per Share (1)

   

Carrying

Value (2)

   

Liquidation

Preference

 

Series A-1

    26,165,827       26,165,827     $ 0.10500     $ 1,341,000     $ 2,747,000  

Series A-2

    22,473,726       22,324,696       0.20130       4,494,000       4,494,000  

Series B

    16,134,433       16,134,433       0.54760       8,777,000       8,835,000  

Series C

    16,404,591       16,229,717       0.28592       4,546,000       4,640,000  

Series D

    24,876,609       24,876,609       1.00496       24,901,000       25,000,000  

Series D-1

    24,075,053       24,075,052       1.31370       32,132,000       31,627,000  
      130,130,239       129,806,334             $ 76,191,000     $ 77,343,000  
   

Number of Shares

 

Outstanding at December 31, 2013

    31,933,862  

Option exercises

    801,691  

RSUs vesting

    15,450  

Common stock issued in connection with employee stock purchase plan

    315,324  

Outstanding at December 31, 2014

    33,066,327  
   

Number of Shares

(in thousands)

   

Weighted-Average Exercise Price

   

Weighted-Average Remaining Contractual Life

(years)

   

Aggregate Intrinsic Value (2)

(in thousands)

 

Balance at December 31, 2011

    4,262     $ 2.93       8.10     $ 6,906  

Granted

    913     $ 4.86                  

Exercised

    (921

)

  $ 0.78                  

Canceled and forfeited

    (239

)

  $ 4.44                  

Balance at December 31, 2012

    4,015     $ 3.78       7.88     $ 8,659  

Granted

    2,069     $ 8.58                  

Exercised

    (192

)

  $ 1.99                  

Canceled and forfeited

    (179

)

  $ 5.44                  

Balance at December 31, 2013

    5,713     $ 5.53       7.31     $ 13,704  

Granted

    783     $ 5.44                  

Exercised

    (802

)

  $ 3.79                  

Canceled and forfeited

    (635

)

  $ 7.47                  

Balance at December 31, 2014

    5,059     $ 5.54       5.78     $ 3,461  

Vested and exercisable as of December 31, 2014

    2,977     $ 4.49       5.33     $ 3,352  

Vested as of December 31, 2014 and expected to vest thereafter (1)

    4,724     $ 5.43       5.75     $ 3,454  
   

Number of Shares (in thousands)

   

Weighted Average Fair Value at Grant

   

Weighted Average Remaining Contractual Life (years)

   

Aggregate Intrinsic Value (1) (in thousands)

 

Balance at December 31, 2012

        $              

Granted

    42     $ 8.21                  

Released

    (4

)

  $ 8.89                  

Balance at December 31, 2013

    38     $ 8.15       2.13     $ 284  

Granted

    1,202     $ 5.89                  

Released

    (15

)

  $ 7.92                  

Canceled and forfeited

    (142

)

  $ 6.05                  

Balance at December 31, 2014

    1,083     $ 5.92       1.39     $ 5,458  
   

Year Ended

December 31, 2014

   

Year Ended

December 31, 2013

 

Expected term (years)

  0.50     0.47  

Volatility

  80%     80%  

Risk-free interest rate

  0.05%-0.08%     0.08%  

Dividend yield

       
   

December 31,

 
   

2014

   

2013

 

Common stock reserved:

               

Common stock options

    5,058,641       5,713,106  

Restricted stock units

    1,082,939       38,124  

Warrants to purchase common stock

    24,838       24,838  

Shares available for future issuance under the 2013 Plan

    984,455       936,457  

Employee stock purchase plan

    504,014       500,000  
      7,654,887       7,212,525  
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Cost of revenue

  $ 342     $ 185     $ 128  

Sales and marketing

    2,776       1,806       1,215  

Research and development (1)

    482       346       184  

General and administrative

    2,174       1,497       515  

Total stock-based compensation

  $ 5,774     $ 3,834     $ 2,042  
   

Year 2013 through

August 12

   

Year Ended December

31, 2012

 

Expected term (years)

 

3.41-5.76

   

4.01-6.00

 

Volatility

 

80%

   

80%

 

Risk-free interest rate

 

0.47% - 1.77%

   

0.54% - 0.95%

 

Dividend yield

       
   

August 12,

2013

   

December 31,

2012

 

Warrant (series A-2)

  $ 203     $ 144  

Warrant (series C)

    223       157  

Total fair value

  $ 426     $ 301  

Issue Date

 

Security

 

Expiration

 

Exercise Price

   

Number of Shares under Warrants

 

December 31, 2006

 

Common Stock

 

December 31, 2018

  $ 1.2078       24,838  
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Expected term (years)

 

6.00

   

5.51-6.12

   

5.60-6.07

 

Volatility

 

80%

   

80%

   

65% - 90%

 

Risk-free interest rate

 

1.74%-2.02%

   

1.06%-1.72%

   

0.73%-1.09%

 

Dividend yield

           

Weighted-average fair value

 

$3.76

   

$5.89

   

$3.06

 
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Expected term (years)

    6.00       8.24       9.65  

Volatility

    80.0

%

    80.0

%

    80.0

%

Risk-free interest rate

    2.02

%

    2.64

%

    1.70

%

Dividend yield

                 
Note 12 - Net Income (Loss) Per Share (Tables)
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Numerator:

                       

Net income (loss)

  $ (8,745

)

  $ 321     $ 6,266  

Less: Undistributed earnings allocated to participating securities

                (6,177

)

Net income (loss) attributable to common stockholders

  $ (8,745

)

  $ 321     $ 89  
                         

Denominator:

                       

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:

                       

Basic

    32,591       15,752       4,716  

Weighted-average effect of potentially dilutive shares:

                       

Employee stock options and restricted stock units

          1,459       790  

Convertible preferred, common stock warrants and employee stock purchase plan

          39       39  

Diluted

    32,591       17,250       5,545  

Net income (loss) per share attributable to common stockholders:

                       

Basic

  $ (0.27

)

  $ 0.02     $ 0.02  

Diluted

  $ (0.27

)

  $ 0.02     $ 0.02  
   

As of December 31,

 
   

2014

   

2013

   

2012

 

Convertible preferred stock

                21,634  

Employee stock options and restricted stock units

    5,944       1,280       205  

Warrants to purchase common stock

    25              
Note 13 - Income Taxes (Tables)
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Domestic

  $ (9,899

)

  $ 369     $ 6,289  

Foreign

    930       622       589  

Total

  $ (8,969

)

  $ 991     $ 6,878  
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Current:

                       

Federal

  $ 21     $ (106

)

  $ (220

)

State

    270       (493

)

    (190

)

Foreign

    (403

)

    (260

)

    (146

)

Total

    (112

)

    (859

)

    (556

)

Deferred:

                       

Federal

    221       221        

State

    105       23        

Foreign

    10       (55

)

    (56

)

Total

    336       189       (56

)

Total income tax (expense) benefit

  $ 224     $ (670

)

  $ (612

)

   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Tax benefit at federal statutory rate

    34.0

%

    34.0

%

    34.0

%

State, net of federal effect

    4.2       31.3       1.8  

Foreign rate differential

    3.5       (21.4

)

    (2.9

)

Stock-based compensation

    (9.7

)

    76.5       7.2  

Change in valuation allowance

    (28.8

)

    (51.4

)

    (46.7

)

Other non-deductible expenses

    (0.6

)

    (1.2

)

    8.0  

Other

    (0.1     (0.2

)

    7.5  

Total provision

    2.5

%

    67.6

%

    8.9

%

   

December 31,

 
   

2014

   

2013

 

Deferred tax assets:

               

Accruals and reserves

  $ 1,563     $ 1,314  

Net operating loss carryforwards

    4,604       4,307  

Tax credit carryforwards

    1,476       1,234  

Stock-based compensation

    2,600       1,977  

Foreign taxes

    38       19  

Total deferred tax assets

    10,281       8,851  
                 

Fixed assets

    (512

)

    (283

)

State taxes

    (578

)

    (1,025

)

Purchased intangible assets

    (465

)

    (792

)

Total deferred tax liabilities

    (1,555

)

    (2,100

)

                 

Valuation allowance

    (9,157

)

    (7,524

)

Total net deferred tax liabilities

  $ (431

)

  $ (773

)

   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Unrecognized benefit - beginning of period

  $ 358     $ 246     $ 158  

Gross increases - current year tax provisions

    101       112       88  

Unrecognized benefit - end of period

  $ 459     $ 358     $ 246  
Note 15 - Segments (Tables)
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]
   

Years Ended December 31,

 
   

2014

   

2013

   

2012

 

Domestic

  $ 149,617     $ 134,846     $ 110,872  

International

    28,162       16,282       5,872  

Total revenue

  $ 177,779     $ 151,128     $ 116,744  
Note 1 - Organization and Description of Business (Details) (USD $)
0 Months Ended 12 Months Ended 0 Months Ended 1 Months Ended
Aug. 12, 2013
Dec. 31, 2013
Aug. 12, 2013
IPO [Member]
Jul. 24, 2013
Reverse Stock Split [Member]
Note 1 - Organization and Description of Business (Details) [Line Items]
 
 
 
 
Stockholders' Equity Note, Stock Split, Conversion Ratio
 
 
 
Stock Issued During Period, Shares, New Issues
 
 
5,125,000 
 
Sale of Stock, Price Per Share
 
 
$ 9.00 
 
Proceeds from Issuance Initial Public Offering
$ 40,000,000 
$ 39,976,000 
 
 
Fees and Commissions
 
 
3,200,000 
 
Payments of Stock Issuance Costs
 
 
$ 2,900,000 
 
Convertible Preferred Stock, Shares Issued upon Conversion
 
 
21,840,537 
 
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
 
 
53,983 
 
Note 2 - Summary of Significant Accounting Policies (Details) (USD $)
0 Months Ended 12 Months Ended
Aug. 7, 2013
Aug. 12, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Letters of Credit Outstanding, Amount
 
 
$ 300,000 
$ 300,000 
 
Allowance for Loan and Lease Losses, Write-offs
 
 
739,000 
 
 
Amortization of Intangible Assets
 
 
700,000 
800,000 
200,000 
Deferred Rent Credit, Noncurrent
 
 
300,000 
200,000 
 
Advertising Expense
 
 
1,700,000 
1,500,000 
600,000 
Adjustments to Additional Paid in Capital, Warrant Issued
400,000 
400,000 
 
426,000 1
 
Computer Software, Intangible Asset [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Finite-Lived Intangible Asset, Useful Life
 
 
3 years 
 
 
Internal Use Software Development Costs [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Capitalized Computer Software, Additions
 
 
2,400,000 
2,000,000 
800,000 
Amortization of Intangible Assets
 
 
$ 1,100,000 
$ 1,000,000 
$ 900,000 
Sales Revenue, Net [Member] |
Customer Concentration Risk [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Concentration Risk, Percentage
 
 
8.00% 
19.00% 
21.00% 
Accounts Receivable [Member] |
Customer Concentration Risk [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Concentration Risk, Percentage
 
 
9.00% 
17.00% 
 
Minimum [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Property, Plant and Equipment, Useful Life
 
 
3 years 
 
 
Maximum [Member]
 
 
 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) [Line Items]
 
 
 
 
 
Property, Plant and Equipment, Useful Life
 
 
5 years 
 
 
Note 2 - Summary of Significant Accounting Policies (Details) - Changes in Allowance for Doubtful Accounts (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Allowance for doubtful accounts receivable:
 
 
 
Balance
$ 1,056 
$ 563 
$ 170 
Allowance for doubtful accounts receivable
1,154 
493 
393 
Doubtful accounts receivable write-offs
(739)
 
 
Balance
$ 1,471 
$ 1,056 
$ 563 
Note 3 - Acquisitions (Details) (USD $)
1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended
Dec. 28, 2012
Series D-1 Convertible Preferred Stock [Member]
Crowd Science Inc [Member]
Dec. 31, 2013
Treasury Stock [Member]
Dec. 28, 2012
Cash Withheld At Closing [Member]
Crowd Science Inc [Member]
Dec. 28, 2012
Crowd Science Inc [Member]
Dec. 28, 2012
Crowd Science Inc [Member]
Note 3 - Acquisitions (Details) [Line Items]
 
 
 
 
 
Payments to Acquire Businesses, Gross
 
 
 
$ 1,100,000 
$ 1,033,000 
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares
2,000,000 
66,666 
 
400,000 
 
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned
 
 
 
3,300,000 
3,300,000 
Business Combination, Consideration Transferred
 
 
 
4,400,000 
4,422,000 
Business Combination, Contingent Consideration, Liability
 
 
$ 49,000 
 
 
Business Combination Contingent Shares Issuable
 
 
 
400,000 
400,000 
Share Price
 
 
 
$ 1.67 
$ 1.67 
Note 3 - Acquisitions (Details) - Aggregate Purchase Consideration and Estimated Fair Values of the Assets Acquired and Liabilities Assumed (USD $)
In Thousands, unless otherwise specified
1 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 28, 2012
Crowd Science Inc [Member]
Dec. 28, 2012
Crowd Science Inc [Member]
Fair value of purchase consideration:
 
 
 
 
Cash consideration
 
 
$ 1,100 
$ 1,033 
Cash escrow account
 
 
 
49 
2,000,000 Series D-1 preferred stock shares
 
 
 
3,319 
Series D-1 issuance costs
 
 
 
21 
Total purchase consideration
 
 
4,400 
4,422 
Fair value of net assets acquired:
 
 
 
 
Cash
 
 
259 
259 
Accounts receivable
 
 
163 
163 
Other current assets
 
 
63 
63 
Property and equipment
 
 
14 
14 
Other assets
 
 
30 
30 
Developed technology
 
 
2,600 
2,600 
Goodwill
3,902 
3,902 
3,013 
3,013 
Total assets acquired
 
 
6,142 
6,142 
Accounts payable and accruals
 
 
461 
461 
Deferred revenue
 
 
223 
223 
Deferred tax liability
 
 
1,036 
1,036 
Total liabilities assumed
 
 
1,720 
1,720 
Net assets acquired
 
 
$ 4,422 
$ 4,422 
Note 3 - Acquisitions (Details) - Unaudited pro-forma financial information of the results of Operations as if the Acquisition had Occurred on January 1, 2011 (Crowd Science Inc [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Crowd Science Inc [Member]
 
Note 3 - Acquisitions (Details) - Unaudited pro-forma financial information of the results of Operations as if the Acquisition had Occurred on January 1, 2011 [Line Items]
 
Revenue
$ 117,441 
Net income
$ 2,676 
Basic and diluted net income (loss) per share attributable to common stockholders (in Dollars per share)
$ 0.00 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details)
12 Months Ended
Dec. 31, 2014
Minimum [Member]
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) [Line Items]
 
Marketable Securities Maturities
3 months 
Maximum [Member]
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) [Line Items]
 
Marketable Securities Maturities
24 months 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
$ 66,674 
$ 64,114 
Gross Unrealized Gains
Gross Unrealized Losses
(30)
(10)
Fair Value
66,645 
64,107 
Cash [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
26,755 
24,255 
Fair Value
26,755 
24,255 
Money Market Funds [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
11,304 
18,371 
Fair Value
11,304 
18,371 
Cash and Cash Equivalents [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
38,059 
42,626 
Fair Value
38,059 
42,626 
Corporate Bond Securities [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
28,615 
17,892 
Gross Unrealized Gains
Gross Unrealized Losses
(30)
(10)
Fair Value
28,586 
17,885 
Marketable Securities [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
28,615 
21,488 
Gross Unrealized Gains
Gross Unrealized Losses
(30)
(10)
Fair Value
28,586 
21,481 
Commercial Paper [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
 
2,396 
Fair Value
 
2,396 
Certificates of Deposit [Member]
 
 
Note 4 - Cash, Cash Equivalents and Marketable Securities (Details) - Summary of Marketable Securities [Line Items]
 
 
Cost
 
1,200 
Fair Value
 
$ 1,200 
Note 5 - Fair Value of Financial Instruments (Details) (USD $)
12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Aug. 12, 2013
Dec. 31, 2014
Marketable Securities [Member]
Maximum [Member]
Dec. 31, 2014
Marketable Securities [Member]
Minimum [Member]
Dec. 31, 2013
Other Income [Member]
Dec. 31, 2012
Other Income [Member]
Note 5 - Fair Value of Financial Instruments (Details) [Line Items]
 
 
 
 
 
 
 
Derivative Liability, Fair Value, Gross Liability
 
 
$ 400,000 
 
 
 
 
Fair Value Adjustment of Warrants
$ 125,000 
$ 100,000 
 
 
 
$ 100,000 
$ 100,000 
Financial Instruments Maturities, Short-Term
 
 
 
12 months 
3 months 
 
 
Financial Instrument Maturities, Long-Term
 
 
 
2 years 
1 year 
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Fair Value, Inputs, Level 1 [Member] |
Money Market Funds [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
$ 11,304 
$ 18,371 
Fair Value, Inputs, Level 2 [Member] |
Corporate Debt Securities [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
28,586 
17,885 
Fair Value, Inputs, Level 2 [Member] |
Securities (Assets) [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
28,586 
21,481 
Fair Value, Inputs, Level 2 [Member] |
Commercial Paper [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
 
2,396 
Fair Value, Inputs, Level 2 [Member] |
Certificates of Deposit [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
 
1,200 
Money Market Funds [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
11,304 
18,371 
Corporate Debt Securities [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
28,586 
17,885 
Securities (Assets) [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
28,586 
21,481 
Commercial Paper [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
 
2,396 
Certificates of Deposit [Member]
 
 
Note 5 - Fair Value of Financial Instruments (Details) - Money Market Funds, Marketable Securities and Warrant Liability Measured at Fair Value on a Recurring Basis [Line Items]
 
 
Asset fair value
 
$ 1,200 
Note 5 - Fair Value of Financial Instruments (Details) - Changes in Warrant Liability Classified Level 3 (USD $)
In Thousands, unless otherwise specified
0 Months Ended 12 Months Ended
Aug. 7, 2013
Aug. 12, 2013
Dec. 31, 2013
Dec. 31, 2012
Aug. 12, 2013
Changes in Warrant Liability Classified Level 3 [Abstract]
 
 
 
 
 
Beginning balance
 
 
$ 301 
 
$ 426 
Change in fair value recorded in other income (expense), net
 
 
125 
100 
 
Reclassification of warrants to additional paid-in capital in connection with the IPO(1)
$ (400)
$ (400)
$ (426)1
 
 
Note 6 - Property, Equipment, and Software (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Property, Plant and Equipment [Abstract]
 
 
 
Depreciation
$ 3.9 
$ 3.3 
$ 2.6 
Note 6 - Property, Equipment, and Software (Details) - Property, Equipment and Software (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
$ 22,689 
$ 16,104 
Less: accumulated depreciation and amortization
(12,282)
(9,494)
Property, equipment and software, net
10,407 
6,610 
Office Furniture and Fixtures [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
889 
494 
Equipment and Computers [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
10,042 
7,082 
Leasehold Improvements [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
1,967 
1,679 
Computer Software [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
1,891 
1,305 
Internal Use Software Development Costs [Member]
 
 
Property, Plant and Equipment [Line Items]
 
 
Property, Plant, and Equipment, Gross
$ 7,900 
$ 5,544 
Note 6 - Property, Equipment, and Software (Details) - Assets Recorded Under Capital Leases (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Assets Recorded Under Capital Leases [Abstract]
 
 
Gross assets under capital leases
$ 701 
$ 1,910 
Less: accumulated depreciation
(682)
(1,597)
Net assets under capital leases
$ 19 
$ 313 
Note 7 - Goodwill and Intangible Assets (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Jun. 15, 2011
Appealing Media [Member]
Dec. 28, 2012
Crowd Science Inc [Member]
Note 7 - Goodwill and Intangible Assets (Details) [Line Items]
 
 
 
 
 
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net
 
 
 
$ 0.9 
$ 3.0 
Amortization of Intangible Assets
$ 0.7 
$ 0.8 
$ 0.2 
 
 
Note 7 - Goodwill and Intangible Assets (Details) - Intangible Assets Detail (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Carrying Amount
$ 3,107 
$ 3,107 
Accumulated Amortization
(1,778)
(1,058)
Net Carrying Amount
1,329 
2,049 
Developed Technology Rights [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Carrying Amount
2,950 
2,950 
Accumulated Amortization
(1,650)
(951)
Net Carrying Amount
1,300 
1,999 
Weighted-Average Remaining Life (years)
2 years 
2 years 255 days 
Customer Relationships [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Carrying Amount
104 
104 
Accumulated Amortization
(75)
(54)
Net Carrying Amount
29 
50 
Weighted-Average Remaining Life (years)
1 year 146 days 
2 years 146 days 
Noncompete Agreements [Member]
 
 
Finite-Lived Intangible Assets [Line Items]
 
 
Gross Carrying Amount
53 
53 
Accumulated Amortization
$ (53)
$ (53)
Note 7 - Goodwill and Intangible Assets (Details) - Estimated Future Amortization Expense (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Estimated Future Amortization Expense [Abstract]
 
 
2015
$ 671 
 
2016
658 
 
Total future amortization expense
$ 1,329 
$ 2,049 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
$ 16,338 
$ 12,734 
Accrued Compensation [Member]
 
 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
6,884 
5,727 
Accrued Vacation and Other Employee Benefits [Member]
 
 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
3,761 
3,081 
Accrued Customer Incentives [Member]
 
 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
3,884 
1,540 
Accrued Taxes [Member]
 
 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
47 
559 
Other Accrued Expenses [Member]
 
 
Note 8 - Accrued Liabilities (Details) - Accrued Liabilities [Line Items]
 
 
Accrued Liabilities
$ 1,762 
$ 1,827 
Note 9 - Borrowings (Details) (USD $)
0 Months Ended 12 Months Ended 1 Months Ended
Aug. 7, 2013
Aug. 12, 2013
Dec. 31, 2013
Nov. 30, 2014
Maximum [Member]
Silicon Valley Bank [Member]
Nov. 30, 2014
Minimum [Member]
Silicon Valley Bank [Member]
Nov. 30, 2014
Silicon Valley Bank [Member]
May 31, 2012
Silicon Valley Bank [Member]
Jan. 27, 2010
Silicon Valley Bank [Member]
Sep. 25, 2009
Silicon Valley Bank [Member]
Dec. 31, 2014
Silicon Valley Bank [Member]
Note 9 - Borrowings (Details) [Line Items]
 
 
 
 
 
 
 
 
 
 
Line of Credit Facility, Maximum Borrowing Capacity
 
 
 
 
 
$ 25,000,000 
 
 
 
 
Line of Credit Facility Adjusted Quick Ratio
 
 
 
1.4 
1.0 
 
 
 
 
 
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage
 
 
 
 
 
1.00% 
 
 
 
 
Adjustments to Additional Paid in Capital, Warrant Issued
$ 400,000 
$ 400,000 
$ 426,000 1
 
 
 
$ 29,145 
$ 14,572 
$ 14,573 
 
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)
 
 
 
 
 
 
 
 
 
$ 1.7155 
Note 10 - Commitments and Contingencies (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
 
 
 
Operating Leases, Rent Expense, Net
$ 2.7 
$ 2.2 
$ 1.7 
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments [Line Items]
 
Operating lease obligations
$ 8,552 
Capital lease obligations
42 
Traffic acquisition costs and other purchase commitments
10,093 
Total minimum payments
18,687 
Payments Due In Less Than One Year [Member]
 
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments [Line Items]
 
Operating lease obligations
2,324 
Capital lease obligations
42 
Traffic acquisition costs and other purchase commitments
9,943 
Total minimum payments
12,309 
Payments Due Between 1-3 years [Member]
 
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments [Line Items]
 
Operating lease obligations
3,794 
Traffic acquisition costs and other purchase commitments
150 
Total minimum payments
3,944 
Payments Due Between Three and Five Years [Member]
 
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments [Line Items]
 
Operating lease obligations
1,366 
Total minimum payments
1,366 
Payments Due More Than 5 Years [Member]
 
Note 10 - Commitments and Contingencies (Details) - Future Minimum Payments [Line Items]
 
Operating lease obligations
1,068 
Total minimum payments
$ 1,068 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) (USD $)
0 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 0 Months Ended 12 Months Ended
Aug. 7, 2013
Aug. 12, 2013
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Aug. 13, 2013
Dec. 31, 2012
Series A-2 Preferred Stock [Member]
Dec. 31, 2006
Series A-2 Preferred Stock [Member]
Aug. 12, 2013
IPO [Member]
Underwriting Discounts And Commissions [Member]
Aug. 12, 2013
IPO [Member]
Offering Expenses [Member]
Aug. 12, 2013
IPO [Member]
Dec. 31, 2014
10% Or More Shareholder [Member]
The 2004 Plan [Member]
Jul. 31, 2013
10% Or More Shareholder [Member]
2013 Plan [Member]
Dec. 28, 2012
Crowd Science Inc [Member]
Dec. 31, 2014
Crowd Science Inc [Member]
Dec. 31, 2014
Minimum [Member]
The 2004 Plan [Member]
Dec. 31, 2014
The 2004 Plan [Member]
Jul. 31, 2013
2013 Plan [Member]
Dec. 31, 2013
Employee Stock Purchase Plan [Member]
Non Employees [Member]
Aug. 6, 2013
Employee Stock Purchase Plan [Member]
Dec. 31, 2013
Additional Paid in Capital 1 [Member]
Dec. 31, 2013
Non Employees [Member]
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock Issued During Period, Shares, New Issues (in Shares)
 
 
 
 
 
 
 
 
 
 
5,125,000 
 
 
 
 
 
 
 
 
 
 
 
Share Price (in Dollars per share)
 
 
 
 
 
 
$ 0.20130 1
 
 
 
$ 9.00 
 
 
$ 1.67 
 
 
 
 
 
 
 
 
Proceeds from Issuance of Common Stock
 
 
 
 
 
 
 
 
 
 
$ 46,100,000 
 
 
 
 
 
 
 
 
 
 
 
Proceeds from Issuance Initial Public Offering
 
40,000,000 
 
39,976,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Payments of Stock Issuance Costs
 
 
 
 
 
 
 
 
3,200,000 
2,900,000 
2,900,000 
 
 
21,000 
 
 
 
 
 
 
 
 
Conversion of Stock, Shares Converted (in Shares)
 
 
 
21,840,537 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock, Value, Issued
 
 
33,000 
32,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
76,200,000 
 
Preferred Stock, Shares Authorized (in Shares)
 
 
20,000,000 
20,000,000 
 
20,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock, Shares Authorized (in Shares)
 
 
200,000,000 
200,000,000 
 
200,000,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred Stock, Par or Stated Value Per Share (in Dollars per share)
 
$ 0.001 
$ 0.001 
$ 0.001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preferred Stock, Shares Outstanding (in Shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock, Shares, Issued (in Shares)
 
 
33,066,327 
31,933,862 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common Stock, Shares, Outstanding (in Shares)
 
 
33,066,327 
31,933,862 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treasury Stock, Shares (in Shares)
 
 
66,666 
66,666 
 
 
 
 
 
 
 
 
 
 
66,666 
 
 
 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
85.00% 
 
 
 
85.00% 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25.00% 
25.00% 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period
 
 
 
 
 
 
 
 
 
 
 
5 years 
5 years 
 
 
 
10 years 
10 years 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
100.00% 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,000,000 
 
500,000 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.00% 
1.00% 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)
 
 
$ 3.76 
$ 5.89 
$ 3.06 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
 
 
2,000,000 
1,300,000 
3,400,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)
 
 
$ 100,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15.00% 
 
 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)
 
 
783,000 
2,069,000 
913,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8,333 
Capitalized Computer Software, Period Increase (Decrease)
 
 
360,000 
226,000 
79,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
 
 
11,600,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
 
 
2 years 167 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)
 
 
 
 
 
 
 
24,838 
 
 
53,983 
 
 
 
 
 
 
 
 
 
 
 
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)
 
 
 
 
 
 
 
$ 1.2078 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjustments to Additional Paid in Capital, Warrant Issued
400,000 
400,000 
 
426,000 2
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair Value Adjustment of Warrants
 
 
 
$ 125,000 
$ 100,000 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Convertible Preferred Stock (USD $)
Dec. 31, 2012
Class of Stock [Line Items]
 
Shares Authorized
130,130,239 
Shares Issued and Outstanding
129,806,334 1
Carrying Value
$ 76,191,000 2
Liquidation Preference
77,343,000 
Series A-1 Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
26,165,827 
Shares Issued and Outstanding
26,165,827 1
Issuance Price Per Share
$ 0.10500 1
Carrying Value
1,341,000 2
Liquidation Preference
2,747,000 
Series A-2 Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
22,473,726 
Shares Issued and Outstanding
22,324,696 1
Issuance Price Per Share
$ 0.20130 1
Carrying Value
4,494,000 2
Liquidation Preference
4,494,000 
Series B Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
16,134,433 
Shares Issued and Outstanding
16,134,433 1
Issuance Price Per Share
$ 0.54760 1
Carrying Value
8,777,000 2
Liquidation Preference
8,835,000 
Series C Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
16,404,591 
Shares Issued and Outstanding
16,229,717 1
Issuance Price Per Share
$ 0.28592 1
Carrying Value
4,546,000 2
Liquidation Preference
4,640,000 
Series D Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
24,876,609 
Shares Issued and Outstanding
24,876,609 1
Issuance Price Per Share
$ 1.00496 1
Carrying Value
24,901,000 2
Liquidation Preference
25,000,000 
Series D-1 Preferred Stock [Member]
 
Class of Stock [Line Items]
 
Shares Authorized
24,075,053 
Shares Issued and Outstanding
24,075,052 1
Issuance Price Per Share
$ 1.31370 1
Carrying Value
32,132,000 2
Liquidation Preference
$ 31,627,000 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Common Stock Award Activity
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Common Stock Award Activity [Abstract]
 
 
 
Outstanding
31,933,862 
 
 
Option exercises
801,691 
192,000 
921,000 
RSUs vesting
15,450 
 
 
Common stock issued in connection with employee stock purchase plan
315,324 
 
 
Outstanding
33,066,327 
31,933,862 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Option Award Activity (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Option Award Activity [Abstract]
 
 
 
 
Number of Shares
5,059,000 
5,713,000 
4,015,000 
4,262,000 
Weighted-Average Exercise Price
$ 5.54 
$ 5.53 
$ 3.78 
$ 2.93 
Weighted-Average Remaining Contractual Life
5 years 284 days 
7 years 113 days 
7 years 321 days 
8 years 36 days 
Aggregate Intrinsic Value
$ 3,461 1
$ 13,704 1
$ 8,659 1
$ 6,906 1
Vested and exercisable as of December 31, 2014
2,977,000 
 
 
 
Vested and exercisable as of December 31, 2014
$ 4.49 
 
 
 
Vested and exercisable as of December 31, 2014
5 years 120 days 
 
 
 
Vested and exercisable as of December 31, 2014
3,352 1
 
 
 
Vested as of December 31, 2014 and expected to vest thereafter (1)
4,724,000 2
 
 
 
Vested as of December 31, 2014 and expected to vest thereafter (1)
$ 5.43 2
 
 
 
Vested as of December 31, 2014 and expected to vest thereafter (1)
5 years 9 months 2
 
 
 
Vested as of December 31, 2014 and expected to vest thereafter (1)
$ 3,454 1 2
 
 
 
Number of Shares Granted
783,000 
2,069,000 
913,000 
 
Weighted-Average Exercise Price Granted
$ 5.44 
$ 8.58 
$ 4.86 
 
Number of Shares Exercised
(801,691)
(192,000)
(921,000)
 
Weighted-Average Exercise Price Exercised
$ 3.79 
$ 1.99 
$ 0.78 
 
Number of Shares Canceled and Forfeited
(635,000)
(179,000)
(239,000)
 
Weighted-Average Exercise Price Canceled and Forfeited
$ 7.47 
$ 5.44 
$ 4.44 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Restricted Stock Unit Activity (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Restricted Stock Unit Activity [Line Items]
 
 
Weighted Average Fair Value at Grant
$ 100,000.00 
 
Restricted Stock Units (RSUs) [Member]
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Restricted Stock Unit Activity [Line Items]
 
 
Number of Shares
1,083 
38 
Weighted Average Fair Value at Grant
$ 5.92 
$ 8.15 
Weighted Average Remaining Contractual Life (years)
1 year 142 days 
2 years 47 days 
Aggregate Intrinsic Value
$ 5,458 1
$ 284 1
Number of Shares
1,202 
42 
Weighted Average Fair Value at Grant
$ 5.89 
$ 8.21 
Number of Shares
(15)
(4)
Weighted Average Fair Value at Grant
$ 7.92 
$ 8.89 
Canceled and forfeited
(142)
 
Canceled and forfeited
$ 6.05 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used To Value Employee Stock Purchase Rights (Employee Stock Purchase Plan [Member])
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used To Value Employee Stock Purchase Rights [Line Items]
 
 
Expected term (years)
6 months 
171 days 
Volatility
80.00% 
80.00% 
Risk-free interest rate
 
0.08% 
Minimum [Member]
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used To Value Employee Stock Purchase Rights [Line Items]
 
 
Risk-free interest rate
0.05% 
 
Maximum [Member]
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used To Value Employee Stock Purchase Rights [Line Items]
 
 
Risk-free interest rate
0.08% 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Shares of Common Stock Reserved for Future Issuance
Dec. 31, 2014
Dec. 31, 2013
Common stock reserved:
 
 
Common Stock Reserved
7,654,887 
7,212,525 
Common Stock Options [Member}
 
 
Common stock reserved:
 
 
Common Stock Reserved
5,058,641 
5,713,106 
Restricted Stock Units [Member]
 
 
Common stock reserved:
 
 
Common Stock Reserved
1,082,939 
38,124 
Warrants To Purchase Common Stock [Member]
 
 
Common stock reserved:
 
 
Common Stock Reserved
24,838 
24,838 
Shares Available For Future Issuance [Member]
 
 
Common stock reserved:
 
 
Common Stock Reserved
984,455 
936,457 
Employee Stock Purchase Plan [Member]
 
 
Common stock reserved:
 
 
Common Stock Reserved
504,014 
500,000 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - The Fair Value of Option Grants
12 Months Ended 24 Months Ended 12 Months Ended 24 Months Ended 12 Months Ended 24 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2014
Employee Stock Option [Member]
Minimum [Member]
Dec. 31, 2012
Employee Stock Option [Member]
Minimum [Member]
Dec. 31, 2014
Employee Stock Option [Member]
Minimum [Member]
Dec. 31, 2014
Employee Stock Option [Member]
Maximum [Member]
Dec. 31, 2012
Employee Stock Option [Member]
Maximum [Member]
Dec. 31, 2014
Employee Stock Option [Member]
Maximum [Member]
Dec. 31, 2014
Employee Stock Option [Member]
Dec. 31, 2012
Employee Stock Option [Member]
Dec. 31, 2014
Employee Stock Option [Member]
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - The Fair Value of Option Grants [Line Items]
 
 
 
 
 
 
 
 
 
 
 
 
Expected term (years)
 
 
 
 
5 years 219 days 
5 years 186 days 
 
6 years 25 days 
6 years 43 days 
6 years 
 
 
Volatility
 
 
 
 
65.00% 
 
 
90.00% 
 
80.00% 
 
80.00% 
Risk-free interest rate
 
 
 
1.74% 
0.73% 
1.06% 
2.02% 
1.09% 
1.72% 
 
 
 
Weighted-average fair value (in Dollars per share)
$ 3.76 
$ 5.89 
$ 3.06 
 
 
 
 
 
 
$ 3.76 
$ 3.06 
$ 5.89 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Options Granted To Non-Employees (Non Employees [Member])
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Non Employees [Member]
 
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Options Granted To Non-Employees [Line Items]
 
 
 
Expected term (years)
6 years 
8 years 87 days 
9 years 237 days 
Volatility
80.00% 
80.00% 
80.00% 
Risk-free interest rate
2.02% 
2.64% 
1.70% 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Warrants (Warrant [Member])
7 Months Ended 12 Months Ended
Aug. 12, 2013
Dec. 31, 2012
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Warrants [Line Items]
 
 
Volatility
80.00% 
80.00% 
Minimum [Member]
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Warrants [Line Items]
 
 
Expected term (years)
3 years 149 days 
4 years 3 days 
Risk-free interest rate
0.47% 
0.54% 
Maximum [Member]
 
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Assumptions Used to Value Warrants [Line Items]
 
 
Expected term (years)
5 years 277 days 
6 years 
Risk-free interest rate
1.77% 
0.95% 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Summary of Warrants Outstanding (USD $)
In Thousands, unless otherwise specified
Aug. 12, 2013
Dec. 31, 2012
Class of Warrant or Right [Line Items]
 
 
Warrant fair value
$ 426 
$ 301 
Series A-2 Warrant [Member]
 
 
Class of Warrant or Right [Line Items]
 
 
Warrant fair value
203 
144 
Series C Warrant [Member]
 
 
Class of Warrant or Right [Line Items]
 
 
Warrant fair value
$ 223 
$ 157 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Summary of the Warrants to Purchase Common Stock Outstanding (Common Stock [Member], Issued December 31, 2006 [Member], USD $)
12 Months Ended
Dec. 31, 2013
Common Stock [Member] |
Issued December 31, 2006 [Member]
 
Note 11 - Convertible Preferred Stock and Stockholders' Equity (Details) - Summary of the Warrants to Purchase Common Stock Outstanding [Line Items]
 
December 31, 2006
Dec. 31, 2018 
December 31, 2006
$ 1.2078 
December 31, 2006
24,838 
Note 12 - Net Income (Loss) Per Share (Details)
12 Months Ended
Dec. 31, 2014
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Percentage
8.00% 
Series A-1 Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 0.10500 
Series A-2 Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 0.20130 
Series B Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 0.54760 
Series C Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 0.28592 
Series D Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 1.00496 
Series D-1 Preferred Stock [Member]
 
Note 12 - Net Income (Loss) Per Share (Details) [Line Items]
 
Preferred Stock, Dividend Rate, Per-Dollar-Amount
$ 1.31370 
Note 12 - Net Income (Loss) Per Share (Details) - Calculation of Basic and Diluted Net Income (Loss) Per Share (USD $)
In Thousands, except Per Share data, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Calculation of Basic and Diluted Net Income (Loss) Per Share [Abstract]
 
 
 
Net income (loss) (in Dollars)
$ (8,745)
$ 321 
$ 6,266 
Less: Undistributed earnings allocated to participating securities (in Dollars)
 
 
(6,177)
Net income (loss) attributable to common stockholders (in Dollars)
$ (8,745)
$ 321 
$ 89 
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:
 
 
 
Basic
32,591 
15,752 
4,716 
Employee stock options and restricted stock units
 
1,459 
790 
Convertible preferred, common stock warrants and employee stock purchase plan
 
39 
39 
Diluted
32,591 
17,250 
5,545 
Net income (loss) per share attributable to common stockholders:
 
 
 
Basic (in Dollars per share)
$ (0.27)
$ 0.02 
$ 0.02 
Diluted (in Dollars per share)
$ (0.27)
$ 0.02 
$ 0.02 
Note 12 - Net Income (Loss) Per Share (Details) - Equity Shares Excluded from the Calculation of Diluted Net Income Per Share
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Convertible Stock [Member]
 
 
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
 
 
 
Antidilutive Securities
 
 
21,634 
Employee Stock Options and Restricted Stock Units [Member]
 
 
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
 
 
 
Antidilutive Securities
5,944 
1,280 
205 
Warrants To Purchase Common Stock [Member]
 
 
 
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
 
 
 
Antidilutive Securities
25 
 
 
Note 13 - Income Taxes (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 13 - Income Taxes (Details) [Line Items]
 
 
 
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
$ 1.6 
$ 0.1 
$ (2.7)
Deferred Tax Assets, Operating Loss Carryforwards, Domestic
9.5 
 
 
Deferred Tax Assets, Operating Loss Carryforwards, State and Local
15.9 
 
 
Deferred Tax Assets, Tax Credit Carryforwards, Other
0.3 
 
 
Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Domestic Subsidiaries
1.5 
 
 
State and Local Jurisdiction [Member]
 
 
 
Note 13 - Income Taxes (Details) [Line Items]
 
 
 
Deferred Tax Assets, Tax Credit Carryforwards, Research
0.7 
 
 
Internal Revenue Service (IRS) [Member]
 
 
 
Note 13 - Income Taxes (Details) [Line Items]
 
 
 
Deferred Tax Assets, Tax Credit Carryforwards, Research
$ 0.8 
 
 
Note 13 - Income Taxes (Details) - Domestic and Foreign Components of Income (Loss) before Income Taxes (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Domestic and Foreign Components of Income (Loss) before Income Taxes [Abstract]
 
 
 
Domestic
$ (9,899)
$ 369 
$ 6,289 
Foreign
930 
622 
589 
Total
$ (8,969)
$ 991 
$ 6,878 
Note 13 - Income Taxes (Details) - Components of Income Tax (Expense) Benefit (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Current:
 
 
 
Federal
$ 21 
$ (106)
$ (220)
State
270 
(493)
(190)
Foreign
(403)
(260)
(146)
Total
(112)
(859)
(556)
Deferred:
 
 
 
Federal
221 
221 
 
State
105 
23 
 
Foreign
10 
(55)
(56)
Total
340 
189 
(56)
Total income tax (expense) benefit
$ 224 
$ (670)
$ (612)
Note 13 - Income Taxes (Details) - Effective Tax Rates and the Federal Statutory Tax Rate Reconciliation
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Effective Tax Rates and the Federal Statutory Tax Rate Reconciliation [Abstract]
 
 
 
Tax benefit at federal statutory rate
34.00% 
34.00% 
34.00% 
State, net of federal effect
4.20% 
31.30% 
1.80% 
Foreign rate differential
3.50% 
(21.40%)
(2.90%)
Stock-based compensation
(9.70%)
76.50% 
7.20% 
Change in valuation allowance
(28.80%)
(51.40%)
(46.70%)
Other non-deductible expenses
(0.60%)
(1.20%)
8.00% 
Other
(0.10%)
(0.20%)
7.50% 
Total provision
2.50% 
67.60% 
8.90% 
Note 13 - Income Taxes (Details) - Significant Components of Deferred Tax Assets and Liabilities (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2014
Dec. 31, 2013
Deferred tax assets:
 
 
Accruals and reserves
$ 1,563 
$ 1,314 
Net operating loss carryforwards
4,604 
4,307 
Tax credit carryforwards
1,476 
1,234 
Stock-based compensation
2,600 
1,977 
Foreign taxes
38 
19 
Total deferred tax assets
10,281 
8,851 
Fixed assets
(512)
(283)
State taxes
(578)
(1,025)
Purchased intangible assets
(465)
(792)
Total deferred tax liabilities
(1,555)
(2,100)
Valuation allowance
(9,157)
(7,524)
Total net deferred tax liabilities
$ (431)
$ (773)
Note 13 - Income Taxes (Details) - Reconciliation of the Beginning and Ending Balances of the Unrecognized Tax Benefits (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Reconciliation of the Beginning and Ending Balances of the Unrecognized Tax Benefits [Abstract]
 
 
 
Unrecognized benefit - beginning of period
$ 358 
$ 246 
$ 158 
Unrecognized benefit - end of period
459 
358 
246 
Gross increases - current year tax provisions
$ 101 
$ 112 
$ 88 
Note 15 - Segments (Details)
9 Months Ended
Sep. 30, 2014
Segment Reporting [Abstract]
 
Number of Operating Segments
Number of Reportable Segments
Note 15 - Segments (Details) - Segments (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Note 15 - Segments (Details) - Segments [Line Items]
 
 
 
Segment Revenue
$ 177,779 
$ 151,128 
$ 116,744 
Domestic [Member]
 
 
 
Note 15 - Segments (Details) - Segments [Line Items]
 
 
 
Segment Revenue
149,617 
134,846 
110,872 
Foreign [Member]
 
 
 
Note 15 - Segments (Details) - Segments [Line Items]
 
 
 
Segment Revenue
$ 28,162 
$ 16,282 
$ 5,872